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ABSTRACT
Menon, Jyothi, Ph.D., Purdue University, December 2015. Health Care Resource Use,
Health Care Expenditures and Absenteeism Costs Associated with Osteoarthritis. Major
Professor: Joseph Thomas III.
The objectives of this study were to determine incremental health care resource
utilization, incremental health care expenditures, incremental absenteeism, and
incremental absenteeism costs associated with Osteoarthritis. An observational database
analysis was conducted using information from the Medical Expenditure Panel Survey
(MEPS). Individuals 18 years of age or older and employed during 2011 were eligible
for inclusion in the sample for analyses. Individuals were identified with Osteoarthritis
diagnosis based on ICD-9-CM diagnosis codes. Out of a sample of 26,992 individuals,
1,354 were diagnosed with osteoarthritis. Individuals with osteoarthritis were compared
to individuals without osteoarthritis.
Incremental health care resource utilization examined included annual
hospitalization, annual hospital days, annual emergency room visits, annual outpatient
visits. Incremental health expenditures examined included annual inpatient expenditures,
annual outpatient expenditures, annual emergency room expenditures, annual
miscellaneous expenditures, annual medication expenditures and annual total
expenditures. Incremental resource utilization, incremental resource expenditures,
incremental absenteeism and incremental absenteeism costs were estimated using

xv
regression models, adjusting for other covariates including age, gender, sex, region,
marital status, insurance coverage, comorbidities, anxiety, asthma, hypertension and
hyperlipidemia. Multivariate regression models revealed incremental mean annual
resource use associated with osteoarthritis of 0.07 hospitalizations, equal to 70 additional
hospitalizations per 100 osteoarthritic patients annually, and 3.63 outpatient visits, equal
to 363 additional visits per 100 osteoarthritic patients annually. Mean annual incremental
total expenditures associated with osteoarthritis were $2,046. Mean annual incremental
expenditures were largest for inpatient expenditures at $826, followed by mean annual
incremental outpatient expenditures of $659, and mean annual incremental medication
expenditures of $325. Mean annual incremental absenteeism was 2.2 days and mean
annual incremental absenteeism costs were $715.74.
In conclusion, osteoarthritis was associated with considerable incremental health
care resource utilization and expenditures. Presence of osteoarthritis was also associated
with significant incremental absenteeism and incremental absenteeism costs.
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INTRODUCTION
Background
Osteoarthritis
Musculoskeletal disease commonly causes chronic pain and disability (Chen,
Gupte et al. 2012). Due to increasing morbidity and mortality related to musculoskeletal
diseases, the United Nations, the World Health Organization, and thirty-seven countries
recognized the importance of improving understanding and treatment of musculoskeletal
disorders (Woolf and Pfleger 2003). Arthritis is a prevalent musculoskeletal condition
(Murray and Lopez 1997; Blixen and Kippes 1999) and is one of the causes of pain
among older Americans (Chen, Gupte et al. 2012). From 2010 to 2012, 49.7 percent of
adults sixty-five years or older reported an arthritis diagnosis (Centers for Disease
Control and Prevention 2013). It is predicted that by 2030, an estimated sixty-seven
million Americans aged 18 years or older will be diagnosed with arthritis (Hootman and
Helmick 2006). Among all civilian, non-institutionalized United States adults between
eighteen and sixty-four years of age, five percent (8.2 million) reported diagnosed
arthritis and arthritis-attributable work limitations (Theis, Murphy et al. 2007). Direct
medical expenditures for arthritis and other rheumatic conditions in 2003 were estimated
at eighty billion dollars (Centers for Disease Control and Prevention 2007). Indirect costs
including productivity losses for arthritis and other rheumatic conditions in 2003 were
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estimated at forty-seven billion dollars (Centers for Disease Control and Prevention
2007).
Among different types of arthritis, osteoarthritis reportedly affects 27 million
individuals in the United States (Lawrence, Felson et al. 2008). Research for
osteoarthritis have focused on direct costs including medications, hospitalizations,
transport to and from the medical center, and ancillary medical devices (Woo, Lau et al.
2003; Leardini, Salaffi et al. 2004; Gupta, Hawker et al. 2005; Kotlarz, Gunnarsson et al.
2010). Productivity losses or losses at work due to absenteeism or presenteeism because
of osteoarthritis have also been examined (Woo, Lau et al. 2003; Leardini, Salaffi et al.
2004; Gupta, Hawker et al. 2005).

Literature Review
Characteristics of Osteoarthritis
Osteoarthritis is characterized by symptoms related to abnormalities in joints,
subchondral bones and periarticular structures (Altman, Alarcon et al. 1990).
Individuals are diagnosed either due to pathological changes including joint space
narrowing, and bony sclerosis, or due to the presentation of symptoms including pain,
swelling or stiffness, or a combination of both (Altman, Alarcon et al. 1990). In the
United States, it was estimated that twenty-seven million adults suffered from
osteoarthritis in 2005 (Lawrence, Felson et al. 2008). Men have 45 percent lower risk of
incident knee osteoarthritis and 36 percent lower risk of hip osteoarthritis than women
(Srikanth, Fryer et al. 2005).

3
Osteoarthritis usually affect joints in the knee, hip, hand, spine and foot (Newman
et al. 2003). Among United States adults age thirty years or older, it has been estimated
that symptomatic osteoarthritis in the knee occurs in 6 percent of individuals and 13
percent in individuals who are sixty years old or older (Felson and Zhang 1998).
Osteoarthritis of the knee or hip that often lead to significant problems with mobility are
treated with expensive surgical treatments (Guccione, Felson et al. 1994). Knee
replacement surgeries due to osteoarthritis are one of the most commonly performed
orthopedic procedures in the United States. Approximately 50 percent of all joint
arthroplasties performed on the knee, and 97 percent of those are performed for knee
osteoarthritis (United States Bone and Joint Initiative 2011). Osteoarthritis is expected to
increase in the future in developed and developing countries due to increasing aging
population and increasing prevalence of obesity, a risk factor of osteoarthritis (Badley
and Wang 1998; March and Bagga 2004; Hagen, Zwart et al. 2005; Busija, Buchbinder et
al. 2013).

Risk factors
Osteoarthritis and Age
Prevalence of osteoarthritis increases with age (Felson, Naimark et al. 1987;
Kallman, Wigley et al. 1990). Felson and colleagues evaluated 1,424 individuals from
the Framingham Heart study cohort whose ages ranged from sixty-three to ninety-four
years. The Framingham Heart Study investigated development of cardiovascular disease
in an adult population of Framingham, Massachusetts. Felson and colleagues evaluated
these participants for the presence of knee osteoarthritis. Osteoarthritis was diagnosed in
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27 percent of individuals between 65 to 69 years and in 51 percent for individuals who
were 85 years or older (Felson, Naimark et al. 1987). Losina and colleagues estimated
that approximately 10 percent of the United States population will be diagnosed with
knee osteoarthritis by sixty years of age (Losina, Weinstein et al. 2013).

Osteoarthritis and Gender
Prevalence and incidence of osteoarthritis is significantly greater in women than
men, especially after fifty years of age (Oliveria, Felson et al. 1995). Felson and
colleagues estimated that there was a slightly higher prevalence of osteoarthritis in
women (34%) than in men (31%) (Felson, Naimark et al. 1987). Zhang and colleagues
examined 1,041 subjects older than seventy years of age and estimated a higher
prevalence of hand osteoarthritis in women (26.2%) than in men (13.4%) (Zhang, Xu et
al. 2001). Srikanth and colleagues conducted a meta-analysis in differences between
men and women with respect to osteoarthritis incidence. Males as compared to females
had a significantly reduced risk for osteoarthritis in the knee (Incidence Rate Ratio (IRR)
of 0.55), but not in other joints (Srikanth, Fryer et al. 2005).

Osteoarthritis and Race
Anderson and Felson employed data from the HANES I survey which was the
first national Health and Nutrition Examination Survey of 1971-1975, that examined a
total of 5,193 individuals. Black women, as compared to white women, had increased
risk of osteoarthritis (odds ratio = 2.12, 95% confidence interval = 1.39 to 3.23) but no
differences were observed between black men and white men (Anderson and Felson
1988). Sowers and colleagues examined 1,053 women for presence of osteoarthritis in
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Michigan and reported higher prevalence of knee osteoarthritis in black women at 23.1
percent than white women at 8.5 percent (Sowers, Lachance et al. 2000).

Osteoarthritis and Genetic factors
Research suggests that multiple genes and environmental factors can increase
osteoarthritis susceptibility (Felson and Zhang 1998; Jonsson, Manolescu et al. 2003;
Spector and MacGregor 2004). At least 50 percent of cases of osteoarthritis in the hands,
hips and spine are associated with genetic factors (Spector, Cicuttini et al. 1996). Genes
that are considered to have an association with risk of osteoarthritis include VDR, AGC1,
IGF-1 and collagen II, IX, and XI (Spector and MacGregor 2004).

Osteoarthritis and Occupation
Occupational factors have been associated with risk of development of
osteoarthritis. In a textile mill in Virginia, female workers whose jobs required continual
motion had a much higher rate of osteoarthritis than other female workers (Hadler,
Gillings et al. 1978). Felson and colleagues assessed the association between
osteoarthritis in the knee and occupation of the individual. Individuals whose jobs had
repetitive knee motion had higher rate of knee osteoarthritis than men whose jobs did not
include repetitive knee motion (odds ratio = 2.22) (Felson, Hannan et al. 1991). Coggon
and colleagues reported that farmers who regularly lifted weights in excess of ten
kilograms had higher rates of hip osteoarthritis as compared to those who did not lift
weights (odds ratio=3.2) (Coggon, Kellingray et al. 1998).
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Osteoarthritis and Physical activity
Buckwalter and Lane reported that participation in sports that caused repetitive
high levels of impact increased the risk of cartilage degeneration and caused osteoarthritis
(Buckwalter and Lane 1997). Buckwalter and Lane also suggested that people with
abnormal joint alignment or joint injury had greater risk of osteoarthritis (Buckwalter and
Lane 1997). Kujala and colleagues selected 117 male former top-level athletes who had
participated in different sports activities including long-distance running, soccer, weight
lifters and shooters. They reported increased premature risk of development of
osteoarthritis in soccer players and weight lifters due to higher knee injuries (Kujala,
Kettunen et al. 1995).

Osteoarthritis and Comorbid disease conditions
Caporali and colleagues evaluated 29,132 patients with osteoarthritis in Italy and
reported that the most common comorbidities were hypertension (52 percent),
osteoporosis (21 percent), type II diabetes mellitus (15 percent), and chronic obstructive
pulmonary disease (12 percent) (Caporali et al 2005). Marks and Allegrante examined
1,000 hip osteoarthritis surgical patients and reported that 55 percent of the cohort had at
least one comorbid condition related to an insufficiency of the cardiovascular, peripheral
vascular or respiratory systems (Marks and Allegrante 2002). Another risk factor for
osteoarthritis is obesity (Felson, Lawrence et al. 2000; Runhaar, Koes et al. 2011). Being
overweight increases the risk of osteoarthritis (Oliveria, Felson et al. 1995). In the
Framingham Study, women who had a mean weight loss of eleven pounds decreased
their risk for knee osteoarthritis by 50 percent (Felson, Zhang et al. 1992).
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Comorbid conditions including obesity, cardiovascular diseases, anxiety,
hypertension and diabetes have been associated with limitations in activities, and quality
of life in osteoarthritis (Vebrugge, Gates et al. 1991; Creamer, Lethbridge-Cejku et al.
2000; Carporali, Cimmano et al. 2005).

Treatment for Osteoarthritis
There is no treatment that can cure osteoarthritis. Treatment options include
reducing pain and improving function of the joint. Physical therapy, drug therapy and
surgical interventions are some options for relieving pain. Some pharmacological
therapies include administering Nonsteroidal anti-inflammatory drugs (NSAIDs), which
relieve pain and swelling (Tannenbaum, Peloso et al. 2000; Milder, Williams et al. 2011).
NSAIDs are used as first-line treatment for moderate to severe osteoarthritis and
work by inhibiting the COX pathway in the osteoarthritis joint (Tannenbaum, Peloso et
al. 2000). NSAIDs have been commonly prescribed with 80 percent of rheumatologists
prescribing NSAIDs for osteoarthritis (Baum, Kennedy et al. 1985; Hochberg, Perlmutter
et al. 1996). There have been concerns regarding adverse effects due to NSAIDs,
including NSAID related gastrointestinal ulcers (Graham 2000; Tang and Chan 2012).
As a result, second generation COX-2 inhibitors were developed as safer alternatives.
Opioids are becoming more common in treating osteoarthritis. Rutjes and
colleagues conducted a systematic literature review for individuals with osteoarthritis on
pain, function and safety of oral or transdermal opioids as compared to patients with
placebo. They reported that while patients reported 50 percent greater improvement in
pain with opioids than with placebo, there were also higher adverse events reported with
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opioids as compared to placebo (Nuesch, Rutjes et al. 2009). Since prescription opioids
have been reported as a common source of opioid misuse, international osteoarthritis
guidelines recommend use of opioids only in exceptional cases (Dunbar and Katz 1996;
Zacny, Bigelow et al. 2003; Sproule, Brands et al. 2009; Zhang, Nuki et al. 2010).
Other pharmaceutical agents used in the treatment of osteoarthritis are dietary
supplements of glucosamine and chondroitin sulfate (Clegg, Reda et al. 2006),
hyaluronic acid derivatives, NGF monoclonal antibodies (Lane, Schnitzer et al. 2010),
growth factors (Sellers, Peluso et al. 1997), and stem cell therapy (Coleman, Curtin et al.
2010).
Physical rehabilitation is effective in improving symptoms of osteoarthritis
(Ettinger, Burns et al. 1997; Rejeski, Focht et al. 2002). Rejeski and colleagues reported
that physical activity led to an improvement in beliefs of individuals with osteoarthritis
regarding performing their tasks (Rejeski, Ettinger et al. 1998). Rejeski and colleagues
randomly assigned 316 obese individuals with osteoarthritis to one of four interventions:
weight loss due to dietary restrictions, exercise, dietary restrictions and exercise, or
healthy lifestyle control for eighteen months. The authors found that the individuals with
combined diet and exercise intervention, had a significant increase in physical component
summary score on the SF-36 instrument as compared to the control group (p<0.001).
There were no significant differences between groups for the mental component
summary score of the SF-36 (Rejeski, Focht et al. 2002).
Surgical treatment is employed when there is serious damage or pain in the
affected joint (Ronn, Reischl et al. 2011). Surgery may involve repair of the joint
through small incisions. Joint replacement is conducted if damage cannot be repaired
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through incisions (Fortin, Penrod et al. 2002; Bruyere, Pavelka et al. 2008; Ronn, Reischl
et al. 2011).

Osteoarthritis and health-related quality of life
Pain due to osteoarthritis causes functional limitations, stress, depression, and
interferes with performance of various life roles (Gignac, Backman et al. 2008; Sale,
Gignac et al. 2008). Salaffi and colleagues compared individuals suffering from
osteoarthritis with healthy individuals and evaluated their health-related quality of life
using the Short Form-36 (SF-36). One hundred and forty-five patients (54.9 percent) out
of 264 patients reported at least one chronic comorbid disease. Individuals with
osteoarthritis reported significantly lower scores for physical functioning domain (mean
score =48.2) (p<0.001) as compared to individuals without osteoarthritis (mean
score=79.2) (Salaffi, Carotti et al. 2005).
Similarly, Jakobsson and Hallberg conducted a literature review on pain and
health-related quality of life among people aged seventy-five years and older with
osteoarthritis. They reported that individuals with osteoarthritis had more pain,
functional limitations, and lower physical quality of life than those without osteoarthritis
(Jakobsson and Hallberg 2006).
DiBonaventura and colleagues compared individuals with osteoarthritis and
individuals without osteoarthritis using data from the 2009 National Health and Wellness
Survey. There were 2,173 individuals who reported osteoarthritis and 37,599 individuals
without osteoarthritis. Individuals suffering from osteoarthritis (mean age of 52.1 years)
were significantly older than individuals without osteoarthritis (mean age of 41.4 years)
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(p< 0.0001). Most of the individuals were predominantly females (58.2 percent). There
was higher impairment in work for individuals with osteoarthritis (34.4 percent) as
compared to individuals without osteoarthritis (17.8 percent, p<0.001) (Dibonaventura,
Gupta et al. 2011).
Individuals with osteoarthritis have been reported to suffer from higher levels of
depression as compared to individuals without osteoarthritis (Maisiak 1990; Kim, Han et
al. 2011). Apart from the fact that pain in osteoarthritis limits functioning, it also deters a
person from carrying out personal and social functions. This could, in turn, lead to
further depression and anxiety (Williamson and Shaffer 2000).
In summary, three studies reported lower physical functioning among individuals
with osteoarthritis than individuals without osteoarthritis (Salaffi, Carotti et al. 2005;
Jakobsson and Hallberg 2006; Dibonaventura, Gupta et al. 2011). Three studies reported
lower mental functioning among individuals with osteoarthritis than individuals without
osteoarthritis (Maisiak 1990; Williamson and Shaffer 2000; Kim, Han et al. 2011;
Gignac, Backman et al. 2013).

Direct resource utilization and expenditures
All-cause direct utilization and costs for individuals with osteoarthritis
Direct costs are expenditures associated with interventions or treatments for
hospital care, physician services, equipment, medications and laboratory studies (Gabriel,
Crowson et al. 1997). White and colleagues analyzed a de-identified claims data base for
privately insured members between 1998 and 2004. Individuals older than eighteen and
younger than sixty-four years of age and having at least two claims of osteoarthritis
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diagnosis were included. A total of 32,043 osteoarthritis patients comprised the study
sample. Mean age for the total sample was fifty-five years, and sixty percent of the
sample was female. For annual medical utilization, the mean all-cause outpatient visits
was 26.11 with standard deviation of 25.89, the mean all-cause inpatient hospitalization
was 0.60 with standard deviation of 1.57 and the mean all-cause emergency room
utilization was 0.30 with standard deviation of 1.57. Mean all-cause expenditure for
patients diagnosed with osteoarthritis annually was estimated at $8,601 (White, Birnbaum
et al. 2008).

Osteoarthritis-related utilization and cost
Osteoarthritis-related utilization and costs, survey-based studies
Gupta and colleagues mailed a screening questionnaire to individuals older than
fifty-five years in Ontario, Canada to obtain information on self-reported arthritis.
Individuals who reported suffering from osteoarthritis were requested to participate in a
five-year follow up study. Individuals provided their demographic information, health
status, whether they had physician diagnosed arthritis and whether they had joint
replacement through a self-reported questionnaire. Patients were asked to
report the actual costs for the health care services and medical equipments used. Using
information from the questionnaire, osteoarthritis related direct costs in this study were
calculated as sum of equipment, transport, homecare, home aide care, and other
expenditures due to arthritis. Costs due to prescription and non-prescription drugs were
not included, as Canada provides public insurance that covers medication charges. Mean
direct costs were $2,300 per person per year. Logistic regression was used to analyze
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any osteoarthritis-related costs. Age, gender, race, body mass index, income,
employment, education were included in the analyses as predictors to determine the
likelihood of reporting any osteoarthritis related costs. Older individuals as compared to
younger individuals were more likely to have osteoarthritis-related costs (p<0.001).
Women were more likely than men to having osteoarthritis-related costs (p<0.001)
(Gupta, Hawker et al. 2005).
Woo and colleagues estimated osteoarthritis related direct utilization and costs
of osteoarthritis in Hong Kong in 2001. Patients with osteoarthritis were recruited from
four different types of clinic of Hong Kong. Participants were given a questionnaire that
collected data on sociodemographic information and information on disease. Information
on all hospital or clinic services related to osteoarthritis in the past twelve months was
collected. Means and standard deviations for costs and utilization for groups with mild
osteoarthritis and severe osteoarthritis were calculated. Direct costs of osteoarthritis were
summation of costs due to hospital inpatient and outpatient services, drug treatments,
transport to hospital or clinic for the previous twelve months for osteoarthritis. Mean
emergency visits annually for osteoarthritis were 1.8 days, mean outpatient visits
annually for osteoarthritis were 3.4 days, mean duration of hospitalization visits annually
for osteoarthritis were 36.1 days, mean duration of physiotherapy visits annually for
osteoarthritis were 19.7 days, and average duration of occupational therapy annually for
osteoarthritis were 18.8 days. Average direct costs for a person per year ranged from
$192 dollars for mild osteoarthritis to $658 Hong Kong dollars for severe osteoarthritis
(Woo, Lau et al. 2003).
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Leardini and colleagues evaluated a cohort of 254 patients from twenty-nine
rheumatology institutes suffering from osteoarthritis in Italy from 2000 to 2001. Patients
in the rheumatology institutes reported to a rheumatologist in each institute. Data
collection was conducted by the rheumatologists who obtained information on the
patient’s sociodemographic characteristics and clinical information about the disease
with a survey. Direct costs related to osteoarthritis including hospitalizations, visits to
general practioners, specialists, laboratory examinations, and physical therapies were
obtained from the survey and summed. Mean age of the sample was sixty-six years, and
75 percent of the sample were females. Mean direct costs per person annually was
calculated. The authors reported mean direct cost of €934 ($1,061) per patient per year,
which included €233 ($256) spent on hospitalization, €209 ($230) on diagnostic
procedures, and €146 ($160) on drug therapy (Leardini, Salaffi et al. 2004).
In summary, three studies found osteoarthritis-related costs using survey data
(Woo, Lau et al. 2003; Leardini, Salaffi et al. 2004; Gupta, Hawker et al. 2005). The
range of osteoarthritis related direct total costs was between $192 (Woo, Lau et al. 2003)
to $2,300 (Gupta, Hawker et al. 2005) per person annually. The range in costs can be
attributed to the different medical insurance systems that are present in different
countries.

Osteoarthritis-related utilization and costs, claims data
Lanes and colleagues evaluated arthritis related direct costs for patients with
osteoarthritis or rheumatoid arthritis from July 1, 1993 to June 30, 1994. Medical records
of patients were obtained from records of a group-model health maintenance
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organization. Utilization included hospital care, outpatient visits and prescriptions.
Individuals thirty years and older, with either rheumatoid arthritis and osteoarthritis and
who were actively enrolled between July 1, 1993 and June 30, 1994 were included.
Individuals diagnosed with rheumatoid arthritis were 365 in number and individuals with
osteoarthritis were 10,101 in number. Mean costs for medication, office visits,
ambulatory visit, and inpatient costs from the utilization records were calculated. An
average individual direct cost of $543 was attributed for osteoarthritis per year while an
average individual direct cost for rheumatoid arthritis was $2,162 annually. Hospital care
was an average cost of $249 per person per year (Lanes, Lanza et al. 1997).
Dunn and colleagues employed data from the IMS or Pharmetrics Integrated
Patient-Centric Database, which are medical and pharmaceutical claims from many
health plans across the United States. Inclusion criteria were a diagnosis of osteoarthritis
from January 1, 2007 through December 31, 2007 and being continuously enrolled for a
year. The sample included 1,116,437 eligible participants with average age of fifty-four
years. Means and standard deviations for inpatient costs, outpatient costs, prescription
medications, and emergency department visits for individuals with osteoarthritis were
calculated from claims. More than half of the sample (56%) were fifty years and older in
age, and 60 percent of the sample were females. Mean inpatient visit annually was one
visit, mean outpatient visit annually were fifteen visits, mean emergency rooms visits
annually were 0.2 visits, and mean medications prescribed annually were 3.8
medications. Average charges annually due to osteoarthritis were estimated to be $5,398
per patient with nearly 40 percent of total charges due to inpatient costs (Dunn and Pill
2009).
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In summary, two studies evaluated osteoarthritis-related utilization and
expenditures using claims data. The average costs annually due to osteoarthritis varied
between $543 per person per year (Lanes, Lanza et al. 1997) to $5,398 per patient per
year (Dunn and Pill 2009). Difference between expenditures can be attributed due to fact
that Dunn and Pill calculated charges submitted by providers and not actual payer costs
while Lanes et al. calculated costs by actual payers.

Incremental direct costs
Incremental utilization and costs, matched cohort analyses
Berger and colleagues examined incremental direct costs for osteoarthritis using
MarketScan® commercial database in the United States (Berger, Hartrick et al. 2011).
Private-sector employees, aged eighteen years or older osteoarthritis in 2007 were
examined. Individuals aged eighteen years or younger, uninsured, or Medicaid
beneficiaries were excluded. Direct care costs were estimated as summation of costs due
to inpatient visits, outpatient visits that included physician visits and emergency
department visits, hospitalizations, and prescription medications. Employed persons with
osteoarthritis were identified (2,399 individuals) and matched on age and sex to an equal
number of individuals without osteoarthritis. Mean age of the sample was 53 years, and
62 percent of the sample were men. Individuals with osteoarthritis also had significanly
higher outpatient visits (28.5 visits) and hospitalizations (0.4 visits) as compared to
individuals without osteoarthritis (11.8 visits) and hospitalizations (P < 0.01).
Individuals with osteoarthritis also had significanly higher hospitalizations (0.4 visits) as
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compared to individuals without osteoarthritis (0.1 visits) (P < 0.01). Annual incremental
cost associated with osteoarthritis was $8,060 per person (Berger, Hartrick et al. 2011).
A study by Macclean and colleagues estimated incremental direct costs due to
osteoarthritis using insurance claims from 1991 and 1993 in a national managed care
organization. Patients with osteoarthritis were matched on age and sex to subjects who
had no insurance claims for osteoarthritis. The sample consisted of 10,000 individuals
with osteoarthritis who were matched to an equal number of individuals without
osteoarthritis on age, sex, and insurance plan. Direct care costs were summation of costs
due to inpatient visits, outpatient visits that included physician visits and emergency
department visits, hospitalizations, and prescription medications. Mean annual direct
costs for individuals with osteoarthritis were $5,294 and mean annual direct costs for
individuals without osteoarthritis were $2,467. Incremental annual direct cost per person
associated with osteoarthritis was $2,827 (MacLean, Knight et al. 1998).
In summary, two studies reported incremental costs associated with osteoarthritis.
Incremental costs associated with osteoarthritis ranged from $2,287 (MacLean, Knight et
al. 1998) to $8,060 per person per year (Berger, Hartrick et al. 2011). Both studies did
not incorporate comorbid disease conditions while reporting incremental estimates.
Maclean et al. conducted their study in 1993, while Berger et al. conducted their studies
in 2011 respectively. Increased expenditures from the study conducted by Maclean et al.
to Berger et al. can be attributed to the increasing costs of medical services with time.
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Incremental utilization and costs, regression analyses
Le and colleagues included individuals older than eighteen years of age with an
osteoarthritis claim in 2007 using MarketScan® Commercial and Medicare Supplemental
Databases. Direct costs were compared between individuals with osteoarthritis and
individuals without osteoarthritis. Individuals with an osteoarthritis diagnosis on an
inpatient or outpatient claim in 2007 were included in the study. The number of
individuals in the study with osteoarthritis was 258,237 patients who were matched to
individuals without osteoarthritis on age, gender, geographic region, health plan type, and
Medicare eligibility. Generalized linear model regressions estimated hospitalizations and
expenditures. Incremental annual mean hospitalizations was 0.3 (p<0.05), incremental
annual mean emergency room visits was 0.2 (p<0.05) and incremental annual mean
outpatient visits was 2.9 (p<0.05). Incremental annual direct cost due to osteoarthritis per
person was $10,941 (Le, Montejano et al. 2012).
DiBonaventura and colleagues used 2009 National Health and Wellness Survey to
estimate direct medical costs of employed individuals in the U.S. Individuals indicated in
the survey if they suffered from arthritis and the type of arthritis they suffered. Of the
39,772 individuals, 2,173 were diagnosed with osteoarthritis. Mean age of individuals
without osteoarthritis was 41 years and mean age of individuals with osteoarthritis was
52 years. More than half of the sample with osteoarthritis were females (58.2 percent),
while 46 percent of individuals with no osteoarthritis were females. Individuals who
reported osteoarthritis were compared to individuals without osteoarthritis. Resource
utilizations estimated were prescriptions, outpatient visits, hospitalizations and
emergency room visits. Direct mean annual costs were $3,702 for individuals with
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osteoarthritis and $2,158 for individuals without osteoarthritis. Mean annual cost
associated with osteoarthritis was estimated at $1,544 per person. (Dibonaventura, Gupta
et al. 2011).
Kotlarz and colleagues used data 1996 to 2005 from the Medical Expenditure
Panel Survey (MEPS) and calculated direct costs for individuals with osteoarthritis and
individuals without osteoarthritis. Individuals eighteen years or older were included in
the study. Generalized linear models were conducted to estimate incremental direct costs
using a zero inflated negative binomial distribution model. Hospital, outpatient,
medication and related medical expenditures were estimated. The authors estimated costs
separately for men and women. The study sample included 74,603 women and 53,890
men. Out-of-pocket direct costs and costs attributable to insurers were calculated.
Among women, there was an increase of out of pocket expenditures by $1,379 per
woman per year due to osteoarthritis and insurer expenditures by $4,833 per person per
year. There was an increase of out-of-pocket expenditures by $694 per man per year due
to osteoarthritis and insurer expenditures by $4,036 per person per year (Kotlarz,
Gunnarsson et al. 2009).
In summary, three studies examined osteoarthritis related incremental direct costs
(Dibonaventura et al 2011; Kotlarz et al. 2009; Le et al. 2012). Kotlarz et al. did not
estimate an annual direct cost per person and instead estimated an average direct cost for
females ($1,379) out-of- pocket and males ($694) out-of-pocket, separately.
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Indirect expenditures associated with osteoarthritis
Indirect expenditures are defined as expenses incurred from the cessation or
reduction of work productivity as a result of morbidity and mortality associated with a
given disease (Gupta, Hawker et al. 2005). Indirect costs consist of reduced productivity
from illness, and costs accrued by family and friends for taking care of an individual due
to his or her disease (Andersson, Levin et al. 2002). Indirect costs incurred due to
absenteeism from the workplace are referred to as absenteeism costs (Andersson, Levin
et al. 2002).

Absenteeism costs
Work productivity has been defined as production output per labor hours (Beaton,
Bombardier et al. 2009). Loss of work productivity can be due to days missed from work
(absenteeism), or difficulties experienced at work due to illness (presenteeism) (Brouwer,
Koopmanschap et al. 1999; Meerding, Jzelenberg et al. 2005). Absenteeism costs are
commonly determined by calculating number of working days lost due to illness and
multiplying with market wage rates (Beaton, Bombardier et al. 2009).

All-cause absenteeism associated with osteoarthritis
White and colleagues analyzed a claims database for privately insured members
from 1998 to 2004 in the United States. In order to calculate absenteeism, the authors
counted a hospital outpatient visit as a half day of absenteeism and a hospital inpatient
visit as a full day of absenteeism. Individual’s daily wage was multiplied with days
absent to obtain absenteeism costs. Average annual absenteeism costs for individuals
with osteoarthritis were $4,603 (White, Birnbaum et al. 2008).
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Osteoarthritis-related absenteeism
Leardini and colleagues evaluated a cohort of 254 patients from twenty-nine
rheumatology institutes suffering from osteoarthritis in Italy from 2000 to 2001. Patients
in the rheumatology institutes reported to a rheumatologist in each institute who obtained
information on the patient’s sociodemographic characteristics and clinical information
about the disease. Information was collected from patients about the number of working
days lost in the past year due to osteoarthritis. Average wages of individuals in different
occupations were obtained from the National Statistics Institute of Italy. Annual working
days missed due to osteoarthritis was multiplied with daily wages to obtain absenteeism
costs. Patients who reported absenteeism due to osteoarthritis reported missing twentyfive working days in the past year, on an average. Absenteeism costs were €1,236
($1,360) per year per patient (Leardini, Salaffi et al. 2004).
Woo and colleagues estimated absenteeism costs of osteoarthritis in Hong Kong
in 2001 for individuals with mild and severe osteoarthritis. Patients with a diagnosis of
osteoarthritis were recruited from different medical clinics. In the survey, participants
provided information related to sick days absent from work due to osteoarthritis.
Participants also provided information about their wage rates. The authors reported that
for individuals with mild arthritis, the average annual costs due to absenteeism or
retirement or change in jobs were $422 and for severe arthritis due to absenteeism or
retirement or change in jobs, the average annual costs were $850 (Woo, Lau et al. 2003).
Gupta and colleagues evaluated absenteeism costs among 1,258 individuals
suffering osteoarthritis in Canada. The authors asked individuals to report the amount of
time they had taken off from work in the past three months due to osteoarthritis. Wages

21
lost due to absenteeism were obtained by using occupation specific wages from 2001
Canadian census and were multiplied with number of working days missed at work.
Mean absenteeism costs were $7,905 per person per annum (Gupta, Hawker et al. 2005).

Osteoarthritis-related incremental absenteeism, regression approach
Kotlarz and colleagues used Medical Expenditure Panel Survey (MEPS) data of
employees in the United States to examine association between osteoarthritis and
absenteeism costs from 1996 to 2005. There were 56,379 women and 61,424 men in the
study. Individuals annual wages were multiplied with annual days missed at workplace
to estimate absenteeism costs. Generalized linear models were conducted to estimate
incremental direct costs using a zero inflated negative binomial model. Variables
included in the analysis were age, occupation, race, gender, region, education, marital
status, presence of diseases including hypertension and hyperlipidemia. Incremental
annual absenteeism associated with osteoarthritis for women was 3.7 days per woman.
Similarly, incremental annual absenteeism associated with osteoarthritis for men was 4.5
days per man. Incremental annual absenteeism costs associated with osteoarthritis for
women were $469 per woman. Similarly, incremental annual absenteeism costs
associated with osteoarthritis for men were $520 per man. (Kotlarz, Gunnarsson et al.
2010).
Berger and colleagues examined absenteeism costs using MarketScan®
commercial database. Employees, aged eighteen years or older with osteoarthritis in
2007 were examined. Absenteeism costs were obtained by multiplying number of hours
absent from work by the mean hourly wage of US full-time civilian employees in 2007
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estimated at $21.08 in year 2007 from United States census. Incremental annual
absenteeism associated with osteoarthritis was 1.8 days. The authors also reported that
average annual absenteeism cost for individuals with osteoarthritis was $3,165, as
compared to average annual absenteeism cost for individuals without osteoarthritis at
$1,747, with incremental absenteeism costs at $1,418 (Berger, Hartrick et al. 2011).
DiBonaventura and colleagues used 2009 National Health and Wellness Survey to
estimate productivity costs in the U.S. Individuals reported absenteeism from their
workplace during the previous seven days. For absenteeism costs, average annual
income values were obtained from the Bureau of Labor Statistics, and then multiplied
with number of days missed at work. Individuals with osteoarthritis were compared to
individuals without osteoarthritis. Incremental annual absenteeism costs were $5,328
(Dibonaventura, Gupta et al. 2011).
There are variations in how absenteeism costs were calculated in literature. While
Kotlarz et al., (Kotlarz, Gunnarsson et al. 2010) and Woo et al.(Woo, Lau et al. 2003),
employed earnings as reported by individuals, DiBonaventura et al.(Dibonaventura,
Gupta et al. 2011), Berger et al. (Berger, Hartrick et al. 2011), Leardini et al. (Leardini,
Salaffi et al. 2004), and Gupta et al. (Gupta, Hawker et al. 2005) used estimated average
wages from census data to estimate absenteeism costs. Studies that used average wages
from census data reported higher absenteeism costs in general than studies that used
wages reported by individuals.
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Study Rationale
Maetzel and colleagues suggested that economic burden of arthritic conditions,
primarily osteoarthritis, will increase as the working population generation gets older
(Maetzel, Li et al. 2004). Kotlarz and colleagues examined absenteeism costs for
employed individuals suffering from osteoarthritis from 1996 to 2005 from the Medical
Expenditure Panel Survey (MEPS) (Kotlarz, Gunnarsson et al. 2010). Berger et al., and
Le et al. also calculated direct and absenteeism costs using Marketscan claims data for
2007 (Berger, Hartrick et al. 2011; Le, Montejano et al. 2012). Berger et al. and Le et al.
however did not adjust for comorbid disease conditions while analyzing incremental
direct expenditures for osteoarthritis. The authors reported that adjusting for comorbid
diseases for individuals with osteoarthritis in future research, would help determine
expenditures attributable solely to osteoarthritis (Berger, Hartrick et al. 2011). The
current study estimated incremental utilization and incremental costs of direct healthcare
associated with osteoarthritis as well as incremental absenteeism and incremental
absenteeism costs associated with osteoarthritis.

Significance
Current estimates of the economic burden of osteoarthritis ignore the cost of some
therapies such as physical therapy and chiropractic care. Current estimates may likely
underestimate the impact of the disease and the need for research into strategies for
prevention and treatment. The findings will provide current burden data to better inform
health policy and resource allocation decisions.
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Objectives
The goal of this study was to assess burden associated with osteoarthritis. The
specific objectives of the study were to:
1. determine incremental annual direct health care resource utilization associated
with osteoarthritis by categories including hospitalizations, hospital days,
emergency room encounters, and outpatient visits
2. determine incremental annual direct health care expenditures associated with
osteoarthritis by categories including total expenditures, inpatient hospital
expenditures, emergency room expenditures, outpatient expenditures, medication
expenditures and miscellaneous expenditures
3. determine incremental annual number of days absent from work associated with
osteoarthritis and
4. determine incremental annual absenteeism costs associated with osteoarthritis
Hypotheses
The current study hypotheses were:
1. presence of osteoarthritis will increase annual direct utilization of health care
resources, including increase in hospitalizations, hospital days, emergency
room encounters, and outpatient room visits
2. presence of osteoarthritis will increase annual direct health care expenditures,
including increase in total expenditures, inpatient hospital expenditures,
emergency room expenditures, outpatient expenditures, medication
expenditures and miscellaneous expenditures
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3. presence of osteoarthritis will increase annual absenteeism from workplace
and
4. presence of osteoarthritis will increase annual absenteeism costs from
workplace
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METHODS
Study Design
An observational database analysis was conducted using data from the Medical
Expenditure Panel Survey (MEPS). Individuals eighteen years old or older with
osteoarthritis were compared to individuals without osteoarthritis. A one-year study
interval was used for analyses.

Data Source
Agency for Healthcare Research and Quality (AHRQ) conducts the Medical
Expenditure Panel Survey (MEPS) nationally (Cohen, Monheit et al. 1996). The MEPS
survey collects information on sociodemographic characteristics, employment
information, health conditions, and health care utilization of individuals surveyed.
Estimates of healthcare expenditures are provided for the United States civilian
noninstitutionalized population by the MEPS (Cohen, Monheit et al. 1996). The MEPS
sample design is a complex survey with disproportionate sampling where Hispanics and
blacks are oversampled. Sampling weights are used to adjust for the complex design of
the survey (Cohen, Monheit et al. 1996).
The MEPS database has two major components: the Household Component and
the Insurance Component. The Household Component provides data from individual
households and their members and their medical providers. The MEPS collects data for
each person in the household on demographic characteristics, health conditions, health
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insurance coverage, income, and employment. The survey has many rounds of
interviewing covering two full calendar years. The present study employed MEPS
household component data for the year 2011.

Study Variables
Osteoarthritis diagnosis
International Classification of Diseases (ICD-9-CM) system codes were used to
identify individuals with osteoarthritis. Individuals with ICD-9-CM code of 715 for
osteoarthritis and allied disorders in the year 2011 were considered to be diagnosed with
osteoarthritis (Centers for Disease Control and Prevention, 2011). The code for
osteoarthritis was obtained from an online 2011 ICD-9-CM and Medical Terminology
dictionary (Centers for Medicaid and Medicare 2011). For the analyses, osteoarthritis
was coded as a binary variable, with ‘1’ indicating presence of the disease, and ‘0’
indicating absence of the disease. Frequencies were tabulated for the osteoarthritis
variable.

Clinical Variables
Charlson Comorbidity Index
The Charlson Comorbidity Index characterizes comorbidities of patients based on
the International Classification of Diseases (ICD) diagnosis codes (Charlson, Pompei et
al. 1987). Higher comorbidity scores indicate a more severe burden of comorbidity. The
Charlson Comorbidity Index score consists of nineteen different disease comorbidity
categories, each allocated a weight of one to six and added to provide a total score, to
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indicate disease burden (Charlson, Pompei et al. 1987). A Charlson Comorbidity Index
score of zero indicates a patient has no or minimal comorbid burden, scores between one
and four indicate moderate burden and scores of greater than or equal to five indicate
substantial burden (Charlson, Pompei et al. 1987). The Charlson Comorbidity Index
scores were created from 2011 claims from MEPS using an algorithm by Romano and
colleagues (Romano, Roos, and Jollis 1993). To control for potential comorbidities,
Charlson Comorbidity Index score was included as a covariate in the analyses and coded
as a continuous variable. Frequencies were tabulated for the Charlson Comorbidity Index
score.

Hypertension
Hypertension in the sample was identified from administrative claims with
corresponding ICD-9-CM diagnosis code for hypertension during the one year period in
2011. The ICD-9-CM code for hypertension is 401 (Centers for Medicaid and Medicare
2011). The code for hypertension was obtained from an online 2011 ICD-9-CM and
Medical Terminology dictionary (Centers for Medicaid and Medicare 2011). For the
analyses, hypertension was coded as a binary variable, with ‘1’ indicating presence of the
disease, and ‘0’ indicating absence of the disease. Frequencies were tabulated for the
hypertension variable.

Hyperlipidemia
Hyperlipidemia in the sample was identified from administrative claims with
corresponding ICD-9-CM diagnosis code for hyperlipidemia during the one year period
in 2011. The ICD-9-CM code for hypertension is 272 (Centers for Medicaid and
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Medicare 2011). The code for hyperlipidemia was obtained from an online 2011 ICD-9CM and Medical Terminology dictionary (Centers for Medicaid and Medicare 2011).
For the analyses, hyperlipidemia was coded as a binary variable, with ‘1’ indicating
presence of the disease, and ‘0’ indicating absence of the disease. Frequencies were
tabulated for the hyperlipidemia variable.

Asthma
Asthma in the sample was identified from administrative claims with
corresponding ICD-9-CM diagnosis code for asthma during the one year period in 2011.
The ICD-9-CM code for hypertension is 493 (Centers for Medicaid and Medicare 2011).
The code for asthma was obtained from an online 2011 ICD-9-CM and Medical
Terminology dictionary (Centers for Medicaid and Medicare 2011). For the analyses,
asthma was coded as a binary variable, with ‘1’ indicating presence of the disease, and
‘0’ indicating absence of the disease. Frequencies were tabulated for the asthma variable.

Anxiety
Anxiety in the sample was identified from administrative claims with
corresponding ICD-9-CM diagnosis code for anxiety during the one year period in 2011.
The ICD-9-CM code for hypertension is 300 (Centers for Medicaid and Medicare 2011).
The code for anxiety was obtained from an online 2011 ICD-9-CM and Medical
Terminology dictionary (Centers for Medicaid and Medicare 2011). For the analyses,
anxiety was coded as a binary variable, with ‘1’ indicating presence of the disease, and
‘0’ indicating absence of the disease. Frequencies were tabulated for the anxiety variable.
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Days missed at workplace
To determine absenteeism, the MEPS survey in 2011 asked individuals to report
number of work days lost because of illness or injury. Days missed at work annually due
to illness or injury in the year 2011 was coded as a count variable.

Sociodemographic variables
Sociodemographic variables included age, gender, degree, race, region, marital
status, and health insurance type. Age of individuals in January of 2011, was coded as a
continuous variable for the analyses. Gender was coded in this study as “0” for males
and “1” for females. Race was coded as a categorical variable including “1” for White,
“2” for Black, “3” for others. Region was coded as a categorical variable including “1”
for Northeast, “2” for Midwest, “3” for South, and “4” for West. Marital status
categories using data of individuals in January of 2011 included “1” for married, “2” for
widowed, “3” for separated, “4” for divorced and “5” for never married.
Highest degree obtained by an individual in year 2011 was coded as “1” for no
degree, “2” for general education degree (GED), “3” for high school diploma, “4” for
bachelor’s degree, “5” for master’s degree or doctorate degree and “6” for other degree.
Health insurance status was coded as a categorical variable with three categories,
“1” as private insurance, and “2” as public insurance and “3” for no insurance.
Frequencies were tabulated for all the sociodemographic variables.

Wage variable
Individuals were asked to report their annual wage in MEPS for 2011. Based on
a report by Bureau of Labor Statistics, number of working days annually is calculated by
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considering there are five working days per week, excluding federal holidays (Bureau of
Labor Statistics 2011). For the purposes of the current study, number of working days in
2011 was calculated by excluding federal holidays and weekends, obtaining 250 days.
Annual wages were divided by number of working days in 2011 to obtain daily wages.
Daily wage was coded as a continuous variable. Daily wage was multiplied with annual
days missed at the workplace to obtain annual absenteeism costs.

Healthcare utilization variables
Health care resource utilization among persons with osteoarthritis was estimated
from individuals’ claims during 2011 for hospitalizations, hospital days, outpatient visits,
and emergency room visits. One visit at an outpatient facility was defined as a
summation of all visits to that facility per day. For example, if a patient visited an
outpatient office two times in one day the resultant visit count for that day was one
outpatient visit. Similarly, for an emergency room visit if a patient visited an emergency
room once on a particular day, the resultant visit count for emergency room was one.
Hospitalizations were determined by identifying and counting the number of
unique confinements per patient. One admittance to the hospital for a person was
considered as one hospitalization for the person. Number of hospital days spent by each
patient were identified by subtracting the patient’s admit date and discharge date at the
hospital for each visit.

Healthcare expenditures
Health care resource expenditures among persons with osteoarthritis was
estimated from individuals’ claims during 2011. For inpatient expenditures, standard
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cost of the inpatient admission was added to professional fees associated with the
confinement. Total hospitalization costs per patient were calculated by adding
expenditures from all hospital episodes. If there were multiple visits to the same facility
on the same day, a visit-level summation of expenditures was generated to obtain one
record per visit (outpatient facility or emergency room) per day. Total annual emergency
room expenditures and total annual outpatient expenditures per patient were calculated by
adding facility-specific expenditures for the patient in the specified one-year period.
Total annual prescription expenditures per patient, were calculated by adding standard
prices for all medication claims during the specified one year period. Total
miscellaneous expenditures were calculated per person by adding all costs not included in
any other resource category during the specified one year period.

Ethical Considerations
Application for human subjects research was approved by the Institutional
Review Board at Purdue University, West Lafayette, Indiana. Research proceeded upon
approval.

Study Sample
Sample Inclusion Criteria
Osteoarthritis cohort sample
Osteoarthritis cohort included all employed people eighteen years old or older
using claims data from 2011. ICD-9-CM codes were used to identify employees with
osteoarthritis: 715 for osteoarthritis and other allied disorders.
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Comparison sample
Osteoarthritis cohort was compared to a comparison cohort consisting of all
employed individuals in year 2011, eighteen years old or older and employed, but with no
diagnosis of osteoarthritis.

Sample Exclusion Criteria
Individuals missing any information on age, sex, race, region, marital status,
insurance were excluded. Individuals missing any information on number of days missed
at work in 2011 were excluded. Individuals who had missing information for their wages
in MEPS were excluded.

Statistical Analysis
SAS for UNIX version 9.3 (SAS Institute, 2001 Cary, NC) and STATA for UNIX
version 12 was used for analyses. An a priori alpha level of 0.05 was used for all
analyses. Frequency distributions were developed and Chi-square tests were used to
assess statistical differences between persons with or without osteoarthritis on age,
gender, geographical region, marital status, race, insurance status, hypertension,
hyperlipidemia, anxiety, asthma, and Charlson Comorbidity Index.

All-cause Health Care Resource Utilization
All-cause Hospitalization
All-cause hospitalizations were determined for the year 2011. Unadjusted means
and 95 percent confidence intervals were computed. Residuals were not normally
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distributed and Wilcoxon Mann Whitney tests were used to detect differences between
individuals with osteoarthritis and those without osteoarthritis.

All-cause Hospital days
All-cause hospital days were determined for the year 2011. Unadjusted means
and 95 percent confidence intervals were computed. Residuals were not normally
distributed and Wilcoxon Mann Whitney tests were used to detect differences between
individuals with osteoarthritis and those without osteoarthritis.

All-cause Outpatient visits
All-cause outpatient visits were determined for the year 2011. Unadjusted means
and 95 percent confidence intervals were computed. Residuals were not normally
distributed and Wilcoxon Mann Whitney tests were used to detect differences between
individuals with osteoarthritis and those without osteoarthritis.

All-cause Emergency room visits
All-cause emergency room visits were determined for the year 2011. Unadjusted
means and 95 percent confidence intervals were computed. Residuals were not normally
distributed and Wilcoxon Mann Whitney tests were used to detect differences between
individuals with osteoarthritis and those without osteoarthritis.
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All-Cause Health Care Expenditures
All-cause Inpatient expenditures
All-cause inpatient expenditures were determined for the year 2011. Unadjusted
means and 95 percent confidence intervals were computed. Residuals were not normally
distributed and Wilcoxon Mann Whitney tests were used to detect differences between
individuals with osteoarthritis and those without osteoarthritis.

All-cause Outpatient expenditures
All-cause outpatient expenditures were determined for the year 2011. Unadjusted
means and 95 percent confidence intervals were computed. Residuals were not normally
distributed and Wilcoxon Mann Whitney tests were used to detect differences between
individuals with osteoarthritis and those without osteoarthritis.

All-cause Emergency room expenditures
All-cause emergency room expenditures were determined for the year 2011.
Unadjusted means and 95 percent confidence intervals were computed. Residuals were
not normally distributed and Wilcoxon Mann Whitney tests were used to detect
differences between individuals with osteoarthritis and those without osteoarthritis.

All-cause Medication expenditures
All-cause medication expenditures were determined for the year 2011.
Unadjusted means and 95 percent confidence intervals were computed. Residuals were
not normally distributed and Wilcoxon Mann Whitney tests were used to detect
differences between individuals with osteoarthritis and those without osteoarthritis.

47
All-cause Miscellaneous expenditures
All-cause miscellaneous expenditures were determined for the year 2011.
Unadjusted means and 95 percent confidence intervals were computed. Residuals were
not normally distributed and Wilcoxon Mann Whitney tests were used to detect
differences between individuals with osteoarthritis and those without osteoarthritis.

All-cause Total expenditures
All-cause total expenditures were determined for the year 2011. Unadjusted
means and 95 percent confidence intervals were computed. Residuals were not normally
distributed and Wilcoxon Mann Whitney tests were used to detect differences between
individuals with osteoarthritis and those without osteoarthritis.

Incremental Direct Resource utilization associated with Osteoarthritis
Based on examination of data distributional characteristics and assessment of fit
of alternative models, a multivariate model for analysis was selected. Direct resource
utilization variables were count variables with discrete values. When a count variable is
used in an ordinary least square regression analysis as a dependent variable, violations of
assumptions to ordinary least square regression can occur (Gardner, Mulvey, and Shaw
1995; Coxe et al. 2009). Residuals of ordinary least squares regression models with
untransformed dependent variables were examined for violation of assumptions. P values
lower than 0.05 for each Kolmogorov-Smirnov test were used to assess whether residuals
were normally distributed (D'Agostino and Stephens 1986). Residuals were observed to
be non-normal, a violation of assumption of ordinary least square regression.
Generalized linear models using maximum likelihood method, as opposed to ordinary
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least squares regression, were then developed and tested for model fit. Presence of over
dispersion of dependent variables was assessed using Vuong tests (Long and Freese
2006; Vuong 1989), and likelihood ratio tests (Long and Freese 2006; Vuong 1989;
Cameron and Trivedi 1986). Zero inflated negative binomial models are employed if
Vuong test statistics are significant at probability less than 0.05 (Vuong 1989). The
incremental or marginal effect of independent variables is then computed by estimating
the expected change in the dependent variable, holding all other independent variables
constant at their mean values.

Incremental Inpatient Hospitalization associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and annual inpatient hospitalizations. Response variable was
annual inpatient hospitalization, which was a count variable. There was presence of over
dispersion where the variance was larger than the mean in the response variable. Vuong
test statistics were significant at probability less than 0.05 indicating the zero-inflated
negative binomial model was required for analysis (Vuong 1989). A binary predictor
variable for osteoarthritis was included in each model and the covariates included age,
gender, degree, race, region, marital status, health insurance type and comorbid
conditions including hypertension, hyperlipidemia, anxiety, asthma and Charlson
Comorbidity Index score. The general regression model developed for estimating
incremental hospitalization is shown below:
Inpatient hospitalization annually =α0 + α1 osteoarthritis + covariates
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The incremental annual hospitalization associated with osteoarthritis is the
estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis.”
Incremental Hospital days associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and annual hospital days. Response variable was annual hospital
days which was a count variable. There was presence of over dispersion where the
variance was larger than the mean in the response variable. Vuong test statistics were
significant at probability less than 0.05 indicating the zero-inflated negative binomial
model was required for analysis (Vuong 1989). A binary predictor variable for
osteoarthritis was included in each model and the covariates included age, gender,
degree, race, region, marital status, health insurance type and comorbid conditions
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index
score. The general regression model developed for estimating incremental hospital days
is shown below:
Hospital days annually = α0 + α1 osteoarthritis + covariates
The incremental annual hospital days associated with osteoarthritis is the estimate
of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis”
Incremental Outpatient Visits associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and annual outpatient visits. Response variable was annual
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outpatient visit which was a count variable. There was presence of over dispersion where
the variance was larger than the mean in the response variable. Vuong test statistics were
significant at probability less than 0.05 indicating the zero-inflated negative binomial
model was required for analysis. A binary predictor variable for osteoarthritis was
included in each model and the covariates included age, gender, degree, race, region,
marital status, health insurance type and comorbid conditions including hypertension,
hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index score. The general
regression model developed for estimating incremental outpatient utilization is shown
below:
Outpatient visits annually = α0 + α1 osteoarthritis + covariates
The incremental annual outpatient visits associated with osteoarthritis is the
estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis”
Incremental Emergency Room visits associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and emergency room visits. Response variable was annual
emergency room visit which was a count variable. There was presence of over dispersion
where the variance was larger than the mean in the response variable. Vuong test
statistics were significant at probability less than 0.05 indicating the zero-inflated
negative binomial model was required for analysis. A binary predictor variable for
osteoarthritis was included in each model and the covariates included age, gender,
degree, race, region, marital status, health insurance type and comorbid conditions
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index
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score. The regression model developed for estimating incremental emergency room
utilization is shown below:
Emergency room visits annually= α0 + α1 osteoarthritis + covariates
The incremental annual emergency room visits associated with osteoarthritis is
the estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis.”
Incremental Direct Resource Expenditures associated with Osteoarthritis
Based on examination of data distributional characteristics and assessment of fit
of alternative models, a multivariate model for analysis was selected. Direct resource
expenditures variables are count variables with discrete values. When a count variable is
used in an ordinary least square regression analysis as a dependent variable, violations of
assumptions to ordinary least square regression can occur (Gardner, Mulvey, and Shaw
1995; Coxe et al. 2009). Residuals of ordinary least squares regression models with
untransformed dependent variables were examined for violation of assumptions. P values
lower than 0.05 for each Kolmogorov-Smirnov test were used to assess whether residuals
were normally distributed (D'Agostino and Stephens 1986). Residuals were observed to
be not normal and a violation of assumption of ordinary least square regression.
Generalized linear models using maximum likelihood method, as opposed to ordinary
least squares regression, were then developed and tested for model fit. Presence of over
dispersion of dependent variables was assessed using Vuong tests (Long and Freese
2006; Vuong 1989), and likelihood ratio tests (Long and Freese 2006; Vuong 1989;
Cameron and Trivedi 1986). Zero inflated negative binomial models are employed if
Vuong test statistics are significant at probability less than 0.05 (Vuong 1989). The
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incremental or marginal effect of independent variables is then computed by estimating
the expected change in the dependent variable, holding all other independent variables
constant at their mean values.

Incremental Inpatient Expenditures associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and inpatient expenditures. Response variable was annual
inpatient expenditures which was a count variable. There was presence of over
dispersion where the variance was larger than the mean in the response variable. Vuong
test statistics were significant at probability less than 0.05 indicating the zero-inflated
negative binomial model was required for analysis. A binary predictor variable for
osteoarthritis was included in each model and the covariates included age, gender,
degree, race, region, marital status, health insurance type and comorbid conditions
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index
score. The regression model developed for estimating incremental inpatient expenditures
is shown below:
Annual inpatient expenditures = α0 + α1 osteoarthritis + covariates
The incremental inpatient expenditures associated with osteoarthritis is the
estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis.”
Incremental Outpatient Expenditures associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and outpatient expenditures. Response variable was annual

53
outpatient expenditures which was a count variable. There was presence of over
dispersion where the variance was larger than the mean in the response variable. Vuong
test statistics were significant at probability less than 0.05 indicating the zero-inflated
negative binomial model was required for analysis. A binary predictor variable for
osteoarthritis was included in each model and the covariates included age, gender,
degree, race, region, marital status, health insurance type and comorbid conditions
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index
score. The regression model developed for estimating incremental outpatient
expenditures is shown below:
Annual outpatient expenditures= α0 + α1 osteoarthritis + covariates
The incremental annual outpatient expenditures associated with osteoarthritis is
the estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis.”
Incremental Emergency Room Expenditures associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and emergency room expenditures. Response variable was annual
emergency room expenditures which was a count variable. There was presence of over
dispersion where the variance was larger than the mean in the response variable. Vuong
test statistics were significant at probability less than 0.05 indicating the zero-inflated
negative binomial model was required for analysis. A binary predictor variable for
osteoarthritis was included in each model and the covariates included age, gender,
degree, race, region, marital status, health insurance type and comorbid conditions
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index
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score. The regression model developed for estimating incremental emergency room
expenditures is shown below:
Annual emergency room expenditure= α0 + α1 osteoarthritis + covariates
The incremental annual emergency room expenditures associated with
osteoarthritis is the estimate of the parameter α1, which is the marginal effect of the
independent variable “osteoarthritis.”
Incremental Medication Expenditures associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and medication expenditures. Response variable was annual
medication expenditures which was a count variable. There was presence of over
dispersion where the variance was larger than the mean in the response variable. Vuong
test statistics were significant at probability less than 0.05 indicating the zero-inflated
negative binomial model was required for analysis. A binary predictor variable for
osteoarthritis was included in each model and the covariates included age, gender,
degree, race, region, marital status, health insurance type and comorbid conditions
including hypertension, hyperlipidemia, anxiety, asthma and Charlson Comorbidity Index
score. The regression model developed for estimating incremental medication
expenditures is shown below:
Annual medication expenditures= α0 + α1 osteoarthritis + covariates
The incremental annual medication expenditures associated with osteoarthritis is
the estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis.”
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Incremental Miscellaneous Expenditures associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and miscellaneous expenditures or expenditures not included in
any other category. Response variable was annual miscellaneous expenditures which
was a count variable. There was presence of over dispersion where the variance was
larger than the mean in the response variable. Vuong test statistics were significant at
probability less than 0.05 indicating the zero-inflated negative binomial model was
required for analysis. A binary predictor variable for osteoarthritis was included in each
model and the covariates included age, gender, degree, race, region, marital status, health
insurance type and comorbid conditions including hypertension, hyperlipidemia, anxiety,
asthma and Charlson Comorbidity Index score. The regression model developed for
estimating incremental annual miscellaneous expenditures is shown below:
Annual miscellaneous expenditures= α0 + α1 osteoarthritis + covariates
The incremental annual miscellaneous expenditures associated with osteoarthritis
is the estimate of the parameter α1, which is the marginal effect of the independent
variable “osteoarthritis.”
Incremental Total Expenditures associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and total expenditures. Response variable was total expenditures
which was a count variable. There was presence of over dispersion where the variance
was larger than the mean in the response variable. Vuong test statistics were significant
at probability less than 0.05 indicating the zero-inflated negative binomial model was
required for analysis. A binary predictor variable for osteoarthritis was included in each
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model and the covariates included age, gender, degree, race, region marital status, health
insurance type and comorbid conditions including hypertension, hyperlipidemia, anxiety,
asthma and Charlson Comorbidity Index score. The regression model developed for
estimating incremental annual total expenditures is shown below:
Annual total expenditures= α0 + α1 osteoarthritis + covariates
The incremental annual total expenditures associated with osteoarthritis is the
estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis.”
Incremental absenteeism associated with Osteoarthritis
A generalized linear model was developed to estimate independent association
between osteoarthritis and absenteeism. Response variable was annual absenteeism
which was a count variable. There was presence of over dispersion where the variance
was larger than the mean in the response variable. Vuong test statistics were significant
at probability less than 0.05 indicating the zero-inflated negative binomial model was
required for analysis. Days absent from work due to illness annually was employed as
the response variable. A binary variable indicating the presence or absence of
osteoarthritis was included as predictor variable. Covariates for the model included age,
gender, degree, race, region, marital status, health insurance type and comorbid
conditions including hypertension, hyperlipidemia, anxiety, and asthma as well as
Charlson Comorbidity Index. The general regression model developed for estimating
incremental absenteeism is shown below:
Days absent from work annually= α0 + α1 osteoarthritis + covariates
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The incremental absenteeism associated with osteoarthritis is the estimate of the
parameter α1, which is the marginal effect of the independent variable “osteoarthritis.”
Incremental Absenteeism Expenditures associated with Osteoarthritis
Daily wage was estimated by dividing annual wages by number of working days
in the year. Working days in year 2011 was assumed to be 250 days after accounting for
holidays and weekends. All working days lost due to health problems was multiplied
with daily wage of an individual to obtain annual absenteeism costs (Liu et al. 2002; Krol
and Brouwer 2014). A generalized linear model was developed to estimate independent
association between osteoarthritis and absenteeism costs. Response variable was annual
absenteeism costs which was a count variable. There was presence of over dispersion
where the variance was larger than the mean in the response variable. Vuong test
statistics were significant at probability less than 0.05 indicating the zero-inflated
negative binomial model was required for analysis. The response variable was annual
absenteeism costs. Predictor variable included a binary variable indicating the presence
or absence of osteoarthritis. Covariates for the model included age, gender, degree, race,
marital status, and health insurance type, and comorbid conditions for osteoarthritis
including hypertension, hyperlipidemia, asthma, anxiety and Charlson Comorbidity Index
scores. The general regression model developed for estimating incremental absenteeism
costs is shown below:
Annual absenteeism costs = α0 + α1 osteoarthritis + covariates
The incremental annual absenteeism costs associated with osteoarthritis is the
estimate of the parameter α1, which is the marginal effect of the independent variable
“osteoarthritis.”
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RESULTS
Sample for Analyses
Figure 1 shows the sample selection procedure and results of selection of the
sample for analyses. The total number of individuals who participated in MEPS
Household Component of the Medical Expenditure Panel Survey in 2011 were 35,313.
After excluding 5,762 individuals who were younger than eighteen years of age, 29,551
individuals remained. After excluding 2,559 unemployed individuals, 26,992 remained.
Out of 26,992 individuals, 1,354 individuals had a diagnosis of osteoarthritis. Individuals
with osteoarthritis were compared to individuals without osteoarthritis on age, sex, race,
region, marital status, insurance, comorbidities including hypertension, hyperlipidemia,
anxiety, asthma, and Charlson Comorbidity Index scores.

Distribution of Individuals by Age
The distribution by age for the sample used in analyses is shown in Table 1. For
the total sample, approximately half of the total sample were (48%) were between 18 and
54 years of age. Data on age were not available for 7,252 individuals. Individuals 55
years old or older comprised 27 percent of the total sample.
For individuals with osteoarthritis, a majority of the sample, 1,040 individuals
(77.12%) were 55 years or older. However, for individuals without osteoarthritis, 6,078
individuals (23.70 %) were 55 years or older in age.
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35,313 individuals in
2011 MEPS
5,762
individuals < 18
years of age
29,551 individuals

2,559
individuals
unemployed
29,551 individuals

1,354 individuals
with osteoarthritis

25,638 individuals
without
osteoarthritis

Figure 1. Sample Selection for Analyses
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Table 1. Distribution of Study Sample by Age (n=26,992)
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
________________
_______________
________________
Age
Number Percent
Number Percent
Number Percent Prob.1
______________________________________________________________________
<0.001
18 to 34

5,633

22.10

27

2.01

5,606

21.84

35 to 44

3,289

12.19

78

5.82

3,211

12.52

45 to 54

3,327

13.69

195

14.54

3,505

13.67

55 to 64

3,279

12.12

389

29.04

2,890

11.27

65 and over

3,839

14.24

651

48.08

3,188

12.43

Missing
7,252 25.66
14
1.03
7,238
28.23
______________________________________________________________________
1
Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Distribution of Individuals by Gender
The distribution by gender for the sample used in analyses is shown in Table 2.
For the total sample, the proportion of females was higher (54.43%) than males
(45.57%). Similarly, for individuals with osteoarthritis, a majority of the sample were
females (70%) and for individuals without osteoarthritis, 54 percent were females.

Distribution of Individuals by Race
Table 3 shows the distribution of the sample by race. For the total sample,
majority were whites (70.55%), followed by blacks (19.89%) and the rest belonged to
other races. Similarly, for individuals with osteoarthritis, 78 percent were whites,
followed by blacks at 15 percent, and the rest of the cohort were from other races. For
individuals without osteoarthritis, 70 percent were white, 20 percent were black, and rest
were from other races.

Distribution of Individuals by Region
Table 4 shows the distribution of the sample by geographical region. The sample
was divided into four regions including the Midwest, Northeast, South and West. Most
individuals belonged to the south with 9,953 individuals (37.11%), followed by
individuals from the west at 6,881 individuals (25.65%) from the west, 5,793 individuals
(21.60%) from Midwest and 4,196 individuals (15.64%) from Northeast. Among persons
with osteoarthritis, a total of 500 persons (36.93%) were from the South. The proportion
of individuals from the comparison group without osteoarthritis from the South was
similar at 36.87 percent.
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Table 2. Distribution of Study Sample by Gender (n=26,992)
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
________________
______________
________________
Gender Number Percent
Number Percent
Number Percent Prob.1
______________________________________________________________________
<0.001
Male
12,301
45.57
402
29.69
11,889
46.41
Female 14,691
54.43
952
70.31
13,739
53.59
______________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Table 3. Distribution of Study Sample by Race (n=26,992)
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
________________
______________
________________
Race
Number Percent
Number Percent
Number Percent Prob.1
______________________________________________________________________
<0.001
White
19,044
70.55
1,056
77.99
17,988
70.16
Black

5,369

19.89

207

15.29

5,162

20.13

Other
2,579
9.55
91
6.72
2,488
9.71
______________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Table 4. Distribution of Study Sample by Region (n=26,992)
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
________________
______________
________________
Region Number Percent
Number Percent
Number Percent Prob.1
______________________________________________________________________
0.003
Northeast 4,196
15.64
218
16.10
3,978
15.52
Midwest

5,793

21.60

329

24.30

5,464

21.31

South

9,953

37.11

500

36.93

9,453

36.87

West

6,881

25.65

293

21.64

6,588

25.70

Missing
169
0.63
14
1.03
155
0.60
______________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Distribution of Individuals by Marital status
Distribution of sample by marital status is shown in Table 5. For marital status,
most of the individuals were not married (45.69%), followed by married individuals
(37.17%), individuals who were widowed (5.5%), divorced (9.24%) and separated
(2.39%). Approximately half of the individuals with osteoarthritis were married, while
47.65% of individuals without osteoarthritis were not married.

Distribution of Individuals by Degree
Table 6 shows the distribution of the sample by educational degree. At least
8,693 individuals (32 percent) of the total sample obtained a high school degree.
Approximately 15 percent of the sample had no degree, followed by 11.5 percent who
had a bachelor’s degree. Only 6 percent of the total sample had a masters or doctorate
degree.
Similarly, for individuals with osteoarthritis, 621 (45.86%) individuals had a high
school degree, followed by 226 individuals (16.69%) with no degree and 192 individuals
(14.18%) with bachelor’s degree. For individuals without osteoarthritis, proportion of
individuals with high school degree as compared to osteoarthritis cohort was lower at
31.48 percent.
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Table 5. Distribution of Study Sample by Marital status (n=26,992)
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
________________
______________
________________
Marital
Number Percent Number Percent
Number Percent Prob.1
______________________________________________________________________
<0.001
Married
10,034 37.17
670
49.48
9,364
36.52
Widowed

1,485

5.50

247

18.24

1,238

4.83

Divorced

2,495

9.24

274

20.24

2,221

8.66

Separated

646

2.39

47

3.47

599

2.34

Never married 12,332 45.69
116
8.57
12,216
47.65
______________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Table 6. Distribution of Study Sample by highest Degree obtained (n=26,992)
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
_______________ ______________
_____________
Degree
Number Percent
Number Percent
Number Percent Prob.1
______________________________________________________________________
<0.001
No Degree
4,115
15.25
226
16.69
3,889
15.17
GED

879

3.26

80

5.91

799

3.12

High school

8,693

32.21

621

45.86

8,072

31.48

Bachelor

3,105

11.50

192

14.18

2,913

11.36

Masters or Doctorate 1,642

6.08

96

7.83

1,536

6.56

Other
8,558
31.71
129
9.53
8,429
32.87
______________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Distribution of Individuals by Insurance
Table 7 shows the distribution of the sample by insurance coverage. Most of the
sample, 15,032 individuals (55.7%) had private insurance followed by 8,472 individuals
(31.4%) with private insurance and 3,488 individuals (13%) with no insurance.
Similarly, for individuals with osteoarthritis, majority of the sample at 773
individuals (57%) had public insurance, followed by 494 individuals (36.5%) who had
private insurance, and 87 individuals (6.4%) who were uninsured. Similar trend was
observed for individuals without osteoarthritis where 14,259 individuals (55.6%) had
private insurance, 7,978 individuals (31.12%) had public insurance and 3,401 individuals
(13.27%) were uninsured.

Distribution of Individuals by Hypertension
The sample distribution based on presence and absence of hypertension is shown
in Table 8. Hypertension was present in a total of 6,504 persons (24.1%) of the overall
sample. Among persons with osteoarthritis, 844 individuals (62.3%) had a diagnosis of
hypertension, which was significantly higher than among persons without osteoarthritis,
where 5,660 individuals (22.08%) had hypertension.

Distribution of Individuals by Hyperlipidemia
The sample distribution based on presence and absence of hyperlipidemia is
shown in Table 8. Hyperlipidemia was present in a total of 5,001 persons (18.5%) of the
overall sample. Among persons with osteoarthritis, 51 percent had a diagnosis of
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hyperlipidemia, which was significantly higher than among persons without
osteoarthritis, where 16.8 percent had hyperlipidemia.

Distribution of Individuals by Anxiety
The sample distribution based on presence and absence of anxiety is shown in
Table 8. Anxiety was present in a total of 1,710 persons (6.3%) of the overall sample.
Among persons with osteoarthritis, 204 individuals (15%) had a diagnosis of anxiety,
which was significantly higher than among persons without osteoarthritis, where 1,506
individuals (5.9%) had anxiety.

Distribution of Individuals by Asthma
The sample distribution based on presence and absence of asthma is shown in
Table 8. Asthma was present in a total of 2,267 persons (8.4%) of the overall sample.
Among persons with osteoarthritis, 14 percent had a diagnosis of asthma, which was
significantly higher than among persons without osteoarthritis, where 8 percent had
asthma.
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Table 7. Distribution of Study Sample by Insurance Coverage
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
________________
______________
_______________
Insurance Number Percent Number Percent
Number Percent Prob.1
______________________________________________________________________
<0.001
Private
15,032
55.69
773
57.09
14,259
55.62
Public

8,472

31.39

494

36.48

7,978

31.12

Uninsured
3,488
12.92
87
6.43
3,401
13.27
______________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Table 8. Distribution of Study Sample by Comorbid Disease conditions
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
______________
______________ _______________
Comorbidities Number Percent
Number Percent Number Percent Prob.1
______________________________________________________________________
<0.001
Hypertension
6,504 24.10
844 62.33
5,660 22.08
No hypertension

20,488 75.90

510

37.67

19,978

77.92
<0.001

Hyperlipidemia

5,001 18.53

691

51.03

4,310

16.81

No hyperlipidemia 21,991 81.47

663

48.97

21,328

83.19

Anxiety

6.34

204

15.07

1,506

5.87

25,282 93.66

1,150

84.93

24,132

94.13

8.40

192

14.18

2,075

8.09

24,725 91.60

1,162

85.82

23,563

91.91

<0.001
Non Anxiety

1,710

<0.001
Asthma
Non Asthma

2,267

______________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups
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Distribution of Individuals by Charlson Comorbidity Index score
Table 9 describes the distribution of the study sample and compares persons with
osteoarthritis and those without osteoarthritis with respect to Charlson Comorbidity Index
scores. Seventy-four percent of the sample had a Charlson comorbidity score of zero
indicating that they did not have any of the comorbid conditions listed in the Charlson
Comorbidity Index. Approximately, 19 percent of the sample had a score of one and 4
percent of the sample had a score of two. Among individuals with osteoarthritis, 50
percent had a Charlson comorbidity score of zero indicating that they did not have any of
the comorbid conditions listed in the Charlson Comorbidity Index. Individuals with
osteoarthritis and with a score of one on the Charlson Comorbidity Index comprised
30.43 percent of the sample, and 10.19 percent of the group with osteoarthritis had a
score of two. Similarly, among individuals without osteoarthritis, 75.46 percent had a
Charlson comorbidity score of zero. Individuals without osteoarthritis and with a score
of one on the Charlson Comorbidity Index comprised 18.26 percent of the sample.

Distribution of Individuals by Annual Wages
Table 10 shows the distribution of the sample by annual wages. Most of the
sample, 13,733 individuals (50.8%) reported zero wages, followed by 10,349 individuals
(38.7%) who reported annual wages between 0 and 50,000 dollars. For individuals with
osteoarthritis, 793 individuals (58.57%) reported annual wages of zero, followed by 441
individuals (32.57%) with annual wages between 0 and 50,000 dollars. Similarly for
individuals without osteoarthritis, 50.5 percent reported annual wages of zero and 38.9
reported annual wages between 0 and 50,000 dollars.
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Table 9. Distribution of Study Sample by Charlson Comorbidity Index score
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
________________
______________ ______________
Charlson
Comorbidity
Index score
Number Percent
Number Percent Number Percent Prob.1
______________________________________________________________________
<0.001
0
20,024
74.18
678
50.07
19,346
75.46
1

5,094

18.87

412

30.43

4,682

18.26

2

1,194

4.42

138

10.19

1,056

4.12

3

390

1.44

74

5.47

316

1.23

4

118

0.44

28

2.07

90

0.35

5

24

0.09

3

0.22

21

0.08

6 or greater
148
0.55
21
1.55
127
0.50
____________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups

75
Table 10. Distribution of Study Sample by Annual Wages
______________________________________________________________________
Individuals with
Individuals without
Total sample
osteoarthritis
osteoarthritis
(N=26,992)
(N=1,354)
(N=25,638)
_________________ _____________
_______________
Annual wages Number Percent Number Percent
Number Percent Prob.1
______________________________________________________________________
0.982
0
13,733
50.87
793
58.57
12,940
50.47
1 to 50,000
50,001 to 100,000
100,001 to 200,000

10,439

38.67

441

32.57

9,998

38.99

2,262

8.38

90

6.64

2,172

8.47

514

1.90

28

2.06

486

1.89

200,001 to 300,000
44
0.16
2
0.14
42
0.16
____________________________________________________________________
1

Chi-square probability between osteoarthritis and non-osteoarthritis groups

76

Unadjusted Annual Health Care Resource Utilization
Mean unadjusted annual health care utilization for persons with or without
osteoarthritis is reported in Table 11. Mean annual unadjusted hospitalizations among
individuals with osteoarthritis were 0.24 (95 percent confidence interval: 0.21 to 0.26).
Unadjusted hospital days among individuals with osteoarthritis were 5.45 (95 percent
confidence interval: 3.95 to 6.95). Mean annual unadjusted outpatient visits among
individuals with osteoarthritis were 12.93 (95 percent confidence interval: 12.11 to
13.76). Mean annual unadjusted emergency room visits among individuals with
osteoarthritis were 0.33 (95 percent confidence interval: 0.29 to 0.38).
Compared to individuals with osteoarthritis, significantly lower mean unadjusted
hospitalizations, mean unadjusted outpatient room visits and mean unadjusted emergency
room visits were observed among those without osteoarthritis. Mean annual unadjusted
hospitalizations among individuals without osteoarthritis were 0.09 (95 percent
confidence interval: 0.09 to 0.10, P-value <0.001). Mean annual unadjusted outpatient
visits among individuals without osteoarthritis were 4.89 (95 percent confidence interval:
4.76 to 5.01, P-value <0.001). Mean annual unadjusted emergency room visits among
individuals without osteoarthritis were 0.22 (95 percent confidence interval: 0.21 to 0.23,
P-value <0.001). No significant difference in the mean unadjusted hospital days were
observed between persons with osteoarthritis and those without osteoarthritis. Mean
annual unadjusted hospital days among individuals without osteoarthritis were 5.18 (95
percent confidence interval: 4.74 to 5.63, p value=0.532).
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Table 11. Unadjusted Annual Health Care utilization among Individuals with Osteoarthritis and Individuals without Osteoarthritis
____________________________________________________________________________________________________________
With Osteoarthritis
Without Osteoarthritis
(n=1,354)
(n = 25,638)
________________________________
____________________________
Health Care
Utilization Category
Mean
95% Confidence Interval
Mean 95% Confidence Interval
Prob.1
____________________________________________________________________________________________________________
Hospitalization

0.24

0.21 to 0.27

0.09

0.09 to 0.10

<0.001

Hospital days

5.45

3.95 to 6.95

5.18

4.74 to 5.63

0.532

12.93

12.11 to 13.76

4.89

4.76 to 5.01

<0.001

0.33

0.29 to 0.38

0.22

0.21 to 0.23

<0.001

Outpatient visits
Emergency room visits

__________________________________________________________________________________________________________
1

Wilcoxon two-sample probability between osteoarthritis and non-osteoarthritis groups
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Unadjusted Annual Health Care Resource Expenditures
Mean unadjusted annual health care expenditures for persons with or without
osteoarthritis is reported in Table 12. Mean annual unadjusted inpatient expenditures
among individuals with osteoarthritis were $3,563.40 (95 percent confidence interval:
$2,584.90 to $4,541.90). Mean annual unadjusted outpatient expenditures among
individuals with osteoarthritis were $3,242.11 (95 percent confidence interval: $2,922.83
to $3,561.40). Mean annual unadjusted emergency room expenditures among individuals
with osteoarthritis were $295.14 (95 percent confidence interval: $234.20 to $356.08).
Mean annual unadjusted medication expenditures among individuals with osteoarthritis
were $2,366.36 (95 percent confidence interval: $2,137.37 to $2,595.34). Mean annual
unadjusted total expenditures among individuals with osteoarthritis were $ 9,651.50 (95
percent confidence interval: 8,521.18 to 10,781.81).
Compared to individuals with osteoarthritis, significantly lower mean unadjusted
inpatient expenditures, mean unadjusted outpatient expenditures, mean unadjusted
emergency room expenditures, and mean unadjusted medication expenditures and mean
unadjusted total expenditure were observed among those without osteoarthritis. Mean
annual unadjusted inpatient expenditures among individuals without osteoarthritis were
$1,191.64 (95 percent confidence interval: 1,093.91 to 1,289.38, P-value <0.001). Mean
annual unadjusted outpatient expenditures among individuals without osteoarthritis were
$1,223.09 (95 percent confidence interval: 1,172.04 to 1,274.14, P-value <0.001). Mean
annual emergency room expenditures among individuals without osteoarthritis were
$186.98 (95 percent confidence interval: $175.30 to $198.66, P-value <0.001).
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Table 12. Unadjusted Annual Health Care Expenditures in Dollars among Individuals with Osteoarthritis and Individuals without
Osteoarthritis
____________________________________________________________________________________________________________
With Osteoarthritis
Without Osteoarthritis
(n=1,354)
(n = 25,638)
_________________________________
____________________________
Health Care
expenditure Category
Mean
95% Confidence Interval
Mean
95% Confidence Interval
Prob.1
____________________________________________________________________________________________________________
Inpatient expenditures

3,563.40

2,584.90 to 4,541.90

1,191.64

1,093.91 to 1,289.38

<0.001

Outpatient expenditures

3,242.11

2,922.83 to 3,561.40

1,223.09

1,172.04 to 1,274.14

<0.001

Emergency room expenditures 295.14
Medication expenditures
Miscellaneous expenditures

2,366.36
184.48

234.20 to 356.08

186.98

175.30 to 198.66

<0.001

2,137.37 to 2,595.34

962.28

786.47 to 1,138.10

<0.001

143.70 to 225.26

66.90

61.83 to 71.96

<0.001

Total expenditures
9,651.50
8,521.18 to 10,781.81
3,630.91
3415.49 to 3,846.34
<0.001
__________________________________________________________________________________________________________
1

Wilcoxon two-sample probability between osteoarthritis and non-osteoarthritis groups
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Unadjusted Annual Absenteeism
Mean unadjusted absenteeism for persons with or without osteoarthritis is
reported in Table 13. Mean annual unadjusted absenteeism among individuals with
osteoarthritis was 8.72 days (95 percent confidence interval: 6.69 to 10.76). Mean annual
unadjusted absenteeism among individuals without osteoarthritis was significantly lower
than individuals with osteoarthritis (p<0.001). Mean annual unadjusted absenteeism for
individuals without osteoarthritis was 4.95 days (95 percent confidence interval: 4.65 to
5.25).

Unadjusted Annual Absenteeism costs
Mean unadjusted absenteeism costs for individuals with or without osteoarthritis
is reported in Table 14. Mean annual unadjusted absenteeism costs among individuals
with osteoarthritis was $1,393.26 (95 percent confidence interval: $814.91 to $1,971.62).
Mean annual unadjusted absenteeism costs among individuals without osteoarthritis was
significantly lower than individuals with osteoarthritis (p<0.001). Mean annual
unadjusted absenteeism costs for individuals without osteoarthritis were $650.16 (95
percent confidence interval: $601.18 to $699.14).
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Table 13. Unadjusted Annual Absenteeism among Individuals with Osteoarthritis and Individuals without Osteoarthritis
____________________________________________________________________________________________________________
With Osteoarthritis
Without Osteoarthritis
(n=1,354)
(n = 25,638)
_____________________________
____________________________
Category
Mean 95% Confidence Interval
Mean
95% Confidence Interval
Prob.1
____________________________________________________________________________________________________________
Absenteeism
8.72
6.69 to 10.76
4.95
4.65 to 5.25
<0.001
__________________________________________________________________________________________________________
1

Wilcoxon two-sample probability between osteoarthritis and non-osteoarthritis groups
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Table 14. Unadjusted Annual Absenteeism costs in dollars among persons with Osteoarthritis and those without Osteoarthritis
____________________________________________________________________________________________________________
With Osteoarthritis
Without Osteoarthritis
(n=1,354)
(n = 25,638)
________________________________
____________________________
Category
Mean
95% Confidence Interval
Mean
95% Confidence Interval
Prob.1
____________________________________________________________________________________________________________
Absenteeism costs
1393.26
814.91 to 1971.62
650.16
601.18 to 699.14
<0.001
__________________________________________________________________________________________________________
1

Wilcoxon two-sample probability between osteoarthritis and non-osteoarthritis groups
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Association between Osteoarthritis and Incremental Annual Hospitalization
Utilization of healthcare resources, health care expenditures, absenteeism and
absenteeism costs in this study had a high number of observations with zeros. Over
dispersion of each resource utilization variable and expenditure variable evidenced by pvalues less than 0.05 for Vuong tests, suggested a need for a zero-inflated generalized
linear model (Long and Freese 2006; Vuong 1989). Significant likelihood ratio tests,
shown by p-values less than 0.05 indicated that for each dependent variable, zero-inflated
negative binomial models were more suitable than zero-inflated Poisson models (Long
and Freese 2006; Vuong 1989; Cameron and Trivedi 1986).
Zero-inflated negative binomial models were constructed for each of the statistical
models. Results of incremental utilization of hospitalization associated with
osteoarthritis is reported in Table 15. Annual mean incremental hospitalizations
associated with osteoarthritis was significant at 0.07 hospitalizations (p<0.001). There
were no significant differences in mean annual hospitalization between males and
females (p=0.072). Individuals who belonged to other races, exclusive of blacks, had
significantly lower mean annual hospitalizations than whites (0.03 visits, p=0.015).
Individuals who had public insurance had higher mean annual hospitalizations as
compared to individuals with private insurance (0.07 visits, p<0.001). Individuals who
were uninsured had lower mean annual hospitalization utilization as compared to
individuals with private insurance (0.04 visits, p<0.001). Among comorbid conditions,
individuals with hypertension showed significant higher mean annual hospitalization as
compared to individuals without hypertension (0.04 visits, p=0.001).
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Table 15. Association between Osteoarthritis and Annual Incremental utilization of
Hospitalizations (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
0.07
0.01
<0.001
Region
Northeast
Reference
Midwest
0.001
0.01
0.848
South
0.002
0.01
0.844
West
-0.001
0.01
0.870
Age
-0.001
0.01
0.331
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
0.01

0.01

0.072

Reference
0.01
-0.03

0.01
0.01

0.380
0.015

Widowed
0.02
Divorced
-0.01
Separated
-0.05
Never married
-0.03
Degree
No degree
Reference
GED
0.01
High School Diploma
-0.001
Bachelor’s degree
-0.01
Masters or Doctorate
-0.01

0.02
0.01
0.01
0.01

0.384
0.624
0.012
0.003

0.02
0.01
0.01
0.02

0.546
0.515
0.021
0.161

Other degree
Insurance coverage
Private
Public
Uninsured

-0.04

0.01

0.038

Reference
0.07
-0.04

0.01
0.01

<0.001
<0.001

Reference
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Table 15. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
0.04
0.01
0.001
Hyperlipidemia
No hyperlipidemia Reference
Has hyperlipidemia
-0.001
0.01
0.566
Anxiety
No Anxiety
Reference
Has Anxiety
0.04
0.01
0.005
Asthma
No asthma
Reference
Has asthma
-0.001
0.01
0.682
Charlson Comorbidity Index
0.05
0.003
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable.
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Association between Osteoarthritis and Incremental Annual Hospital days
Results of incremental hospital days associated with osteoarthritis is reported in
Table 16. Hospital days spent was not incrementally greater for individuals with
osteoarthritis (0.06 days, p=0.287). There was no significant difference in annual mean
days spent at hospital between females and males (p=0.447). Black individuals had
significantly higher mean annual hospital days than whites (0.10 days, p=0.032).
Individuals who were never married spent fewer days at hospital compared to individuals
who were married (0.09 days, p=0.045). Individuals who had public insurance had
greater mean annual hospital days as compared to individuals with private insurance
(0.34 days, p<0.001).
Among comorbid conditions, individuals with hypertension spent more days at
hospital as compared to individuals without hypertension (0.13 hospital days, p=0.006).
Individuals with hypertension spent more days at hospital as compared to individuals
without hypertension (0.13 hospital days, p=0.006). There were no significant
differences observed in annual mean hospital days spent between individuals who had
hyperlipidemia and those who did not have hyperlipidemia. Similarly, there were no
significant differences observed in annual mean hospital days spent between individuals
who had anxiety and those who did not have anxiety. Also, there were no significant
differences observed in annual mean hospital days spent between individuals who had
asthma and those who did not have asthma. With every unit increase in Charlson
comorbidity index score, there was an additional 0.26 mean annual days at the hospital
(p<0.001).
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Table 16. Association between Osteoarthritis and Annual Incremental utilization of
Hospital days (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
0.06
0.06
0.287
Region
Northeast
Reference
Midwest
-0.03
0.04
0.456
South
0.01
0.04
0.896
West
0.07
0.07
0.340
Age
0.001
0.001
0.336
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
0.04

0.05

0.447

Reference
0.10
0.05

0.04
0.07

0.032
0.495

Widowed
0.05
Divorced
-0.02
Separated
0.04
Never married
-0.04
Degree
No degree
Reference
GED
-0.04
High School Diploma
0.05
Bachelor’s degree
-0.04
Masters or Doctorate
0.07

0.07
0.05
0.09
0.06

0.468
0.891
0.646
0.500

0.08
0.05
0.06
0.12

0.575
0.316
0.490
0.533

Other degree
Insurance coverage
Private
Public
Uninsured

-0.07

0.06

0.297

Reference
0.32
-0.07

0.06
0.05

<0.001
0.213

Reference
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Table 16. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
0.13
0.04
0.006
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
0.01
0.04
0.844
Anxiety
No anxiety
Reference
Has anxiety
0.10
0.05
0.070
Asthma
No asthma
Reference
Has asthma
0.02
0.09
0.775
Charlson Comorbidity Index
0.26
0.03
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Outpatient visits
Results of incremental utilization of outpatient days associated with osteoarthritis
is reported in Table 17. Mean annual outpatient visits were significantly higher for
individuals with osteoarthritis as compared to individuals without osteoarthritis (3.63
visits, p<0.001). With every year increase in age, there was 0.08 increase in outpatient
visits (p<0.001). There were significantly greater mean annual outpatient visits by
females as compared to males (1.73 visits, p<0.001). Black individuals had fewer mean
annual outpatient visits as compared to whites (1.53 visits, p<0.001). Individuals who
belonged to other races also had fewer mean annual outpatient visits as compared to
whites (1.31 visits, p<0.001). Individuals with high school degree had higher mean
annual outpatient visits as compared to individuals without degree (0.62 visits, p=0.029).
Individuals with bachelor’s degree had higher mean annual outpatient visits as compared
to individuals without degree (2.31 visits, p<0.001). Individuals with master’s degree or
doctorate degree had higher mean outpatient visits as compared to individuals without
degree (2.60 visits, p<0.001). Individuals who were uninsured had fewer mean annual
outpatient visits as compared to individuals with private insurance (3.08 visits, p<0.001).
Among comorbid conditions, individuals with hypertension showed significant
higher mean annual outpatient visits as compared to individuals without hypertension
(1.21 visits, p<0.001). Individuals with hyperlipidemia showed significant higher mean
annual outpatient visits as compared to individuals without hyperlipidemia (1.10 visits,
p<0.001). Individuals with anxiety showed significant mean annual outpatient visits as
compared to individuals without anxiety (4.10 visits, p<0.001). .
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Table 17. Association between Osteoarthritis and Annual Incremental Outpatient visits
(n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
3.63
0.50
<0.001
Region
Northeast
Reference
Midwest
-0.38
0.41
0.361
South
-1.52
0.41
<0.001
West
-0.06
0.40
0.884
Age
0.08
0.01
<0.001
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
1.73

0.22

<0.001

Reference
-1.53
-1.31

0.27
0.36

<0.001
<0.001

Widowed
-0.96
Divorced
0.32
Separated
0.10
Never married
0.78
Degree
No degree
Reference
GED
0.80
High School Diploma
0.62
Bachelor’s degree
2.31
Masters or Doctorate
2.60

0.35
0.33
0.85
0.38

0.007
0.325
0.904
0.039

0.66
0.28
0.38
0.49

0.225
0.029
<0.001
<0.001

Other degree
Insurance coverage
Private
Public
Uninsured

1.04

0.43

0.016

Reference
0.55
-3.08

0.30
0.30

0.068
<0.001

Reference
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Table 17. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
1.21
0.27
<0.001
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
1.10
0.23
<0.001
Anxiety
No Anxiety
Reference
Has Anxiety
4.10
0.46
<0.001
Asthma
No Asthma
Reference
Has Asthma
1.15
0.45
0.011
Charlson Comorbidity Index
1.86
0.13
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Emergency room utilization
Results of incremental utilization of emergency rooms associated with
osteoarthritis is reported in Table 18. Mean annual emergency room visits were
significantly higher for individuals with osteoarthritis as compared to individuals without
osteoarthritis (0.009 visits, p<0.001). With every year increase in age, there was 0.002
decrease in mean annual emergency room visits (p<0.001). There was no significant
difference between males and females with respect to the utilization of emergency rooms
(p=0.958). Individuals who were widowed had higher mean annual utilization of
emergency rooms as compared to individuals who were married (0.07 visits, p=0.001).
Individuals who were divorced also had higher annual mean utilization of emergency
rooms as compared to individuals who were married (0.07 visits, p=0.001). Individuals
with bachelor’s degree had significantly fewer mean annual emergency room visits as
compared to individuals without degree (0.09 visits, p<0.001). Individuals with master’s
or doctorate degree had significantly fewer mean annual emergency room visits as
compared to individuals without degree (0.07 visits, p=0.008). Individuals who had
public insurance had higher annual mean emergency room visits as compared to
individuals with private insurance (0.13 visits, p<0.001). Among comorbid conditions,
individuals with hypertension showed significant higher annual mean emergency room
visits as compared to individuals without hypertension (0.07 visits, p<0.001). Individuals
with anxiety showed significant higher mean annual emergency room visits as compared
to individuals without anxiety (0.12 visits, p<0.001).
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Table 18. Association between Osteoarthritis and Annual Incremental Emergency room
utilization (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
0.09
0.02
<0.001
Region
Northeast
Reference
Midwest
0.01
0.02
0.670
South
-0.03
0.02
0.121
West
-0.05
0.02
0.003
Age
-0.002
0.0004
<0.001
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married
Widowed
Divorced
Separated
Never married
Degree
No degree
GED
High School Diploma
Bachelor’s degree
Masters or Doctorate
Other degree
Insurance coverage
Private
Public
Uninsured

Reference
0.0006

0.01

0.958

Reference
0.05
-0.02

0.01
0.02

<0.001
0.194

0.02
0.02
0.03
0.02

0.001
0.001
0.088
0.081

Reference
0.02
-0.01
-0.09
-0.07

0.03
0.01
0.02
0.03

0.543
0.472
<0.001
0.008

-0.06

0.01

0.001

0.02
0.01

<0.001
0.545

Reference
0.07
0.07
0.06
0.03

Reference
0.13
0.01
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Table 18. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
0.07
0.12
<0.001
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
-0.04
0.02
0.034
Anxiety
No anxiety
Reference
Has anxiety
0.12
0.02
<0.001
Asthma
No Asthma
Reference
Has Asthma
0.03
0.02
0.230
Charlson Comorbidity Index 0.05
0.01
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Inpatient Expenditures
Results of annual incremental inpatient expenditures associated with osteoarthritis
is reported in Table 19. Mean annual inpatient expenditures were significantly greater for
individuals with osteoarthritis as compared to individuals without osteoarthritis ($826.38,
p=0.021). With every year increase in age, there was $12.61 increase in mean annual
inpatient expenditures (p=0.031). There were no significant differences in mean annual
inpatient expenditures observed between males and females. Black individuals had
significantly higher mean annual inpatient expenditures as compared to whites ($387.50,
p=0.050). Individuals who were never married had significantly lower annual mean
inpatient expenditures as compared to married individuals ($513.82, p=0.006).
Individuals who were uninsured had lower annual mean inpatient expenditures as
compared to individuals with private insurance ($819.42, p<0.001).
Among comorbid conditions, individuals with hypertension showed no significant
difference in inpatient expenditures as compared to individuals without hypertension
(p=0.083). Individuals with hyperlipidemia showed no significant difference in inpatient
expenditures as compared to individuals without hyperlipidemia (p=0.702). Individuals
with anxiety showed no significant difference in inpatient expenditures as compared to
individuals without anxiety (p=0.309). Individuals with asthma showed no significant
difference in inpatient expenditures as compared to individuals without asthma
(p=0.333). With every unit increase in Charlson comorbidity index score, there was an
additional $772.95 spent in mean inpatient expenditures annually (p<0.001).
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Table 19. Association between Osteoarthritis and Annual Incremental Inpatient
Expenditures (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
826.38
357.33
0.021
Region
Northeast
Reference
Midwest
72.25
187.92
0.701
South
42.92
182.95
0.814
West
377.84
241.70
0.118
Age
12.61
5.83
0.031
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
66.69

170.77

0.696

Reference
387.50
-178.22

197.50
259.57

0.050
0.492

Reference

Widowed
Divorced
Separated
Never married
Degree
No degree
GED
High School Diploma
Bachelor’s degree
Masters or Doctorate

-336.37
-80.04
-300.71
-513.82

239.65
251.27
315.80
187.42

0.160
0.750
0.341
0.006

Reference
139.20
97.03
-119.22
482.72

382.91
235.94
274.12
465.61

0.716
0.681
0.664
0.300

Other degree
Insurance coverage
Private
Public
Uninsured

-197.09

287.25

0.493

Reference
241.07
-819.42

200.79
173.43

0.230
<0.001
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Table 19. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
316.33
182.68
0.083
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
77.55
202.84
0.702
Anxiety
No Anxiety
Reference
Has anxiety
243.44
251.45
0.333
Asthma
No asthma
Reference
Has asthma
-107.35
246.20
0.663
Charlson Comorbidity Index 772.95
104.73
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Outpatient expenditures
Results of annual incremental outpatient expenditures associated with
osteoarthritis is reported in Table 20. Mean annual outpatient expenditures were
significantly higher for individuals with osteoarthritis as compared to individuals without
osteoarthritis ($658.94, p<0.001). With every year increase in age, there was $20.67
increase in mean annual outpatient expenditures (p<0.001). There were significantly
higher mean annual outpatient expenditures for females as compared to males ($223.43,
p=0.012). Black individuals had significantly lower mean annual outpatient
expenditures as compared to whites ($276.32, p=0.015). Individuals who were widowed
had significantly lower annual mean outpatient expenditures as compared to individuals
who were married ($388.92, p=0.015). Individuals who had public insurance had lower
annual mean outpatient expenditures as compared to individuals with private insurance
($405.77, p<0.001). Individuals who were uninsured had lower outpatient expenditures
as compared to individuals with private insurance ($1,205.95, p<0.001). Individuals with
bachelor’s degree had significantly higher outpatient expenditures as compared to
individuals without degree ($830.02, p<0.001).
Among comorbid conditions, individuals with hypertension had significantly
higher outpatient expenditures as compared to individuals without hypertension ($298.83,
p=0.005). Individuals with hyperlipidemia showed higher significant mean annual
outpatient expenditures as compared to individuals without hyperlipidemia ($319.05,
p=0.001). Individuals with anxiety had significantly higher mean annual outpatient
expenditures as compared to individuals without anxiety ($778.26, p<0.001).
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Table 20. Association between Osteoarthritis and Annual Incremental Outpatient
Expenditures (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
658.94
154.29
<0.001
Region
Northeast
Reference
Midwest
-263.93
129.21
0.041
South
-413.90
132.14
0.002
West
-134.07
150.98
0.375
Age
20.67
3.64
<0.001
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married
Widowed
Divorced
Separated
Never married
Degree
No degree
GED
High School Diploma
Bachelor’s degree
Masters or Doctorate
Other degree
Insurance coverage
Any private insurance
Public
Uninsured

Reference
223.43

88.79

0.012

Reference
-276.32
-440.13

113.52
115.33

0.015
<0.001

159.14
137.24
267.94
111.73

0.015
0.528
0.640
0.368

Reference
275.44
421.05
830.02
802.04

174.73
110.64
135.64
185.03

0.115
<0.001
<0.001
<0.001

415.57

146.99

0.005

98.04
104.39

<0.001
<0.001

Reference
-388.92
86.68
-125.36
-100.65

Reference
-405.77
-1205.95
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Table 20. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
298.83
105.34
0.005
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
319.05
100.41
0.001
Anxiety
No anxiety
Reference
Has anxiety
778.26
173.65
<0.001
Asthma
No asthma
Reference
Has asthma
33.31
163.08
0.838
Charlson Comorbidity Index 743.95
57.59
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Emergency Expenditures
Results of annual incremental emergency room expenditures associated with
osteoarthritis is reported in Table 21. Emergency room expenditures were not
significantly different for individuals with osteoarthritis as compared to individuals
without osteoarthritis (p=0.663). With every unit increase in age, there was $1.72
decrease in emergency room expenditures (p=0.010). There were no significant
differences in emergency room expenditures between males and females (p=0.368).
Individuals who were uninsured had lower emergency room expenditures as compared to
individuals with private insurance ($62.88, p=0.001). Individuals with bachelor’s degree
had significantly lower emergency room expenditures as compared to individuals without
degree ($90.22, p=0.035). Individuals with master’s degree or doctorate degree had
significantly lower emergency room expenditures as compared to individuals without
degree ($100.86, p=0.014).
Among comorbid conditions, individuals with hypertension had significantly
higher emergency room expenditures as compared to individuals without hypertension
($81.85, p=0.004). Individuals with anxiety showed significant emergency room
expenditures as compared to individuals without anxiety ($137.96, p<0.001). With every
unit increase in Charlson comorbidity index score, there was an additional $50.17 spent
in mean emergency expenditures annually (p<0.001).
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Table 21. Association between Osteoarthritis and Annual Incremental Emergency room
Expenditures (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
11.92
29.61
0.687
Region
Northeast
Reference
Midwest
32.17
27.30
0.239
South
11.38
23.86
0.633
West
-15.55
28.06
0.579
Age
-1.90
0.73
0.009
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married
Widowed
Divorced
Separated
Never married
Degree
No degree
GED
High School Diploma
Bachelor’s degree
Masters or Doctorate
Other degree
Insurance coverage
Private
Public
Uninsured

Reference
14.44

16.37

0.378

Reference
28.21
-34.24

21.76
33.55

0.195
0.308

37.52
37.25
44.59
21.64

0.709
0.045
0.379
0.347

47.44
40.54
44.40
42.60

0.082
0.429
0.036
0.015

-87.18

49.31

0.077

Reference
-21.57
-68.23

20.72
20.58

0.298
0.001

Reference
-14.00
74.79
39.21
-20.33
Reference
-82.52
-32.05
-93.18
-103.79
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Table 21. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
84.05
29.30
0.004
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
-18.92
29.65
0.523
Anxiety
No anxiety
Reference
Has anxiety
141.42
36.81
0.000
Asthma
No asthma
Reference
Has asthma
4.17
27.39
0.879
Charlson Comorbidity Index 51.80
9.75
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable.
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Association between Osteoarthritis and Incremental Annual Miscellaneous Expenditures
Results of annual incremental other miscellaneous medical expenditures including
medical equipment, supplies, glasses and other medical items associated with
osteoarthritis is reported in Table 22. Annual mean miscellaneous expenditures were not
significantly different for individuals with osteoarthritis as compared to individuals
without osteoarthritis (p=0.117). With every year increase in age, there was $2.23
increase in mean annual miscellaneous expenditures (p<0.001). There was no significant
difference in mean annual miscellaneous expenditures between males and females
(p=0.106). Black individuals had significantly lower mean annual miscellaneous
expenditures as compared to whites ($22.71, p=0.005). Individuals who had public
insurance had lower annual mean miscellaneous expenditures as compared to individuals
with private insurance ($26.28, p=0.015). Individuals with bachelor’s degree had
significantly higher annual mean miscellaneous expenditures as compared to individuals
without degree ($53.08, p<0.001). Individuals with master’s degree or doctorate degree
had significantly higher annual mean miscellaneous expenditures as compared to
individuals without degree ($61.92, p=0.003).
Among comorbid conditions, individuals with hypertension had no significant
difference in annual mean miscellaneous expenditures as compared to individuals without
hypertension (p=0.526).

With every unit increase in Charlson comorbidity index score,

there was an additional $22.50 spent in mean miscellaneous expenditures annually
(p<0.001).
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Table 22. Association between Osteoarthritis Annual Incremental Miscellaneous
expenditures (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
27.96
17.85
0.117
Region
Northeast
Reference
Midwest
9.35
12.88
0.468
South
-4.99
11.01
0.651
West
18.01
12.68
0.156
Age
2.23
0.39
<0.001
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
12.73

7.88

0.106

Reference
-22.71
15.60

8.15
18.23

0.005
0.392

Widowed
1.41
Divorced
15.47
Separated
-32.74
Never married
23.27
Degree
No degree
Reference
GED
-2.18
High School Diploma
17.37
Bachelor’s degree
53.08
Masters or Doctorate
61.92

15.60
14.14
24.19
15.63

0.928
0.274
0.176
0.137

16.88
8.63
13.12
21.09

0.897
0.044
<0.001
0.003

Other degree
Insurance coverage
Private
Public
Uninsured

13.13

15.12

0.385

Reference
-26.28
-75.15

10.84
7.06

0.015
<0.001

Reference
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Table 22. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
7.12
11.24
0.526
Hyperlipidemia
No hyperlipidemia
Has hyperlipidemia
14.84
11.88
0.211
Anxiety
No anxiety
Has anxiety
29.76
21.75
0.171
Asthma
No asthma
Has asthma
3.09
18.72
0.869
Charlson Comorbidity Index 22.50
4.39
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Medication Expenditures
Results of annual incremental medication expenditures associated with
osteoarthritis is reported in Table 23. Annual mean medication expenditures were
significantly higher for individuals with osteoarthritis as compared to individuals without
osteoarthritis ($325.03, p=0.013). With every year increase in age, there was $17.75
increase in mean annual medication expenditures (p<0.001). There was no significant
difference in medication expenditures between males and females (p=0.41). Black
individuals had significantly lower annual mean medication expenditures as compared to
whites ($361.94, p<0.001). Individuals who had public insurance had higher medication
expenditures as compared to individuals with private insurance ($567.61, p<0.001).
Individuals with bachelor’s degree had significantly higher medication expenditures as
compared to individuals without degree ($417.41, p=0.011). Individuals with master’s
degree or doctorate degree had significantly higher medication expenditures as compared
to individuals without degree ($516.66, p=0.024).
Among comorbid conditions, individuals with hypertension had higher mean
annual medication expenditures as compared to individuals without hypertension
($422.22, p<0.001). Individuals with hyperlipidemia had higher annual mean medication
expenditures as compared to individuals without hyperlipidemia ($802.67, p<0.001).
Individuals with anxiety had higher annual mean medication expenditures as compared to
individuals without anxiety ($1,028.34, p<0.001). Individuals with asthma had higher
annual mean medication expenditures as compared to individuals without asthma
($1,096.23, p<0.001).
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Table 23. Association between Osteoarthritis and Annual Incremental Medication
Expenditures (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
325.03
130.27
0.013
Region
Northeast
Reference
Midwest
-265.18
176.97
0.134
South
-200.56
155.90
0.198
West
-250.49
170.01
0.141
Age
17.75
4.03
<0.001
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married
Widowed
Divorced
Separated
Never married
Degree
No degree
GED
High School Diploma
Bachelor’s degree
Masters or Doctorate
Other degree
Insurance coverage
Private
Public
Uninsured

Reference
-71.91

98.08

0.463

Reference
-361.94
-3.48

97.32
254.34

<0.001
0.989

-142.40
-46.58
-132.27
46.83

132.14
121.37
185.74
135.40

0.281
0.701
0.476
0.729

Reference
1738.76
185.01
417.41
516.66

1180.24
119.10
165.01
229.52

0.141
0.120
0.011
0.024

38.52

155.07

0.804

Reference
567.61
-715.10

146.62
103.85

<0.001
<0.001

Reference
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Table 23. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
422.22
89.94
<0.001
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
802.67
93.73
<0.001
Anxiety
No anxiety
Reference
Has anxiety
1028.34
134.05
<0.001
Asthma
No asthma
Reference
Has asthma
1096.23
316.16
<0.001
Charlson Comorbidity Index 731.59
67.15
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Total Expenditures
Results of annual incremental total expenditures associated with osteoarthritis is
reported in Table 24. Mean annual total expenditures were significantly higher for
individuals with osteoarthritis as compared to individuals without osteoarthritis
($2,045.75, p=0.001). With every year increase in age, there was $52.14 increase in
annual mean total expenditures (p<0.001). There was no significant difference in mean
annual total expenditures between males and females (p=0.053). Individuals who had no
insurance had lower annual mean total expenditures as compared to individuals with
private insurance ($2,779.96, p<0.001). Individuals with master’s degree or doctorate
degree had significantly higher total expenditures as compared to individuals without
degree ($1,470.84, p=0.014).
Among comorbid conditions, individuals with hypertension had higher mean
annual total expenditures as compared to individuals without hypertension ($973.03,
p=0.001). Individuals with hyperlipidemia had higher mean annual total expenditures as
compared to individuals without hyperlipidemia ($1,238.88, p=<0.001). Individuals with
anxiety had significant higher annual mean total expenditures as compared to individuals
without anxiety ($2082.09, p<0.001). With every unit increase in Charlson comorbidity
index score, there was an additional $2,494.08 spent in mean total expenditures annually
(p<0.001).
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Table 24. Association between Osteoarthritis and Annual Incremental Total
Expenditures (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
2045.75
603.94
0.001
Region
Northeast
Reference
Midwest
-444.38
318.52
0.163
South
-535.93
331.77
0.106
West
135.04
392.16
0.731
Age
52.14
8.87
<0.001
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
477.48

246.67

0.053

Reference
-486.33
-156.25

261.11
677.23

0.063
0.818

404.33
414.58
778.33
273.30

0.043
0.466
0.952
0.028

1893.92
407.53
473.56
596.92

0.145
0.091
0.084
0.014

258.22

480.86

0.591

Reference
618.82
-2779.76

340.10
263.00

0.069
<0.001

Reference

Widowed
-819.21
Divorced
302.09
Separated
-46.44
Never married
-599.24
Degree
No degree
Reference
GED
2762.10
High School Diploma
689.18
Bachelor’s degree
819.10
Masters or Doctorate
1470.84
Other degree
Insurance coverage
Private
Public
Uninsured
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Table 24. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Hypertension
No hypertension
Reference
Has hypertension
973.03
293.22
0.001
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
1238.88
331.02
<0.001
Anxiety
No anxiety
Reference
Has anxiety
2082.09
347.44
<0.001
Asthma
No asthma
Reference
Has asthma
1066.63
678.76
0.116
Charlson Comorbidity Index 2404.08
160.13
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Absenteeism
Results of annual absenteeism associated with osteoarthritis is reported in Table
25. Annual absenteeism was significantly higher for individuals with osteoarthritis as
compared to individuals without osteoarthritis (2.21 days, p=0.042). With every unit
increase in age, there was 0.03 increase in absenteeism (p=0.030). Females had
significant higher absenteeism than males (1.96 days, p<0.001). Individuals who had
public insurance had higher absenteeism as compared to individuals with private
insurance (2.52 days, p=0.007). Individuals with bachelor’s degree had significantly
lower absenteeism as compared to individuals without degree (3.16 days, p=0.005).
Individuals with master’s degree or doctorate degree had significantly lower absenteeism
as compared to individuals without degree (4.22 days, p<0.001).
Among comorbid conditions, individuals with hypertension had higher significant
absenteeism as compared to individuals without hypertension (1.58 days, p=0.011).
There were no significant differences in annual absenteeism between individuals with
hyperlipidemia and individuals without hyperlipidemia. There were also no significant
differences observed between individuals with anxiety and individuals without anxiety
for annual absenteeism. Individuals with asthma did not show any significant difference
in annual absenteeism as compared to individuals without asthma. Individuals with
higher Charlson Comorbidity Index scores had higher absenteeism as compared to
individuals with lower Charlson Comorbidity index scores (1.48 days, p<0.001)
.
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Table 25. Association between Osteoarthritis and Annual Incremental Annual
Absenteeism (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
2.21
1.09
0.042
Region
Northeast
Reference
Midwest
-0.74
0.53
0.169
South
-0.54
0.56
0.310
West
-1.08
0.53
0.045
Age
0.03
0.01
0.030
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
1.96

0.39

<0.001

Reference
0.39
0.49

0.46
0.69

0.401
0.487

1.50
0.51
0.44

0.546
0.873
0.454

2.11
1.09
1.12
1.15
1.15

0.973
0.053
0.005
<0.001
0.021

0.93
0.46

0.007
0.274

Reference

Widowed
-0.91
Divorced
-0.08
Separated/never married
-0.33
Degree
No degree
Reference
GED
-0.07
High School Diploma
-2.11
Bachelor’s degree
-3.16
Masters or Doctorate
-4.22
Other degree
-2.66
Insurance coverage
Private
Public
Uninsured
Hypertension

Reference
2.52
-0.51
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Table 25. cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
No hypertension
Reference
Has hypertension
1.58
0.62
0.011
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
-0.13
0.58
0.817
Anxiety
No anxiety
Reference
Has anxiety
1.34
0.70
0.056
Asthma
No asthma
Reference
Has asthma
-0.12
0.65
0.845
Charlson Comorbidity Index
1.48
0.21
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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Association between Osteoarthritis and Incremental Annual Absenteeism Expenditures
Results of annual absenteeism costs associated with osteoarthritis is reported in
Table 26. Annual absenteeism costs was significantly higher for individuals with
osteoarthritis as compared to individuals without osteoarthritis ($715.74, p=0.05). With
every unit increase in age, there was 8.91 increase in absenteeism costs (p=0.002).
Females had significantly higher absenteeism costs than males ($206.85, p=0.001).
Individuals who had no insurance had lower absenteeism costs as compared to
individuals with private insurance ($321.73, p<0.001). Individuals with bachelor’s
degree had significantly higher absenteeism costs as compared to individuals without
degree ($269.14, p=0.015). Individuals with master’s degree or doctorate degree had
significantly higher absenteeism costs as compared to individuals without degree
($255.36, p=0.048).
Among comorbid conditions, individuals with hypertension had higher significant
absenteeism costs as compared to individuals without hypertension ($234.90, p=0.016).
There were no significant differences in annual absenteeism costs between individuals
with hyperlipidemia and individuals without hyperlipidemia. There were also no
significant differences observed between individuals with anxiety and individuals without
anxiety for annual absenteeism costs. Individuals with asthma did not show any
significant difference in annual absenteeism costs as compared to individuals without
asthma. Individuals with higher Charlson Comorbidity Index scores had higher
absenteeism costs as compared to individuals with lower Charlson Comorbidity index
scores ($212.28, p<0.001).
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Table 26. Association between Osteoarthritis and Annual Incremental Absenteeism
Expenditures (n=26,992)
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
Osteoarthritis
715.74
370.63
0.050
Region
Northeast
Reference
Midwest
-195.97
81.90
0.017
South
-127.40
91.67
0.165
West
-210.38
82.13
0.010
Age
8.91
2.88
0.002
Sex
Male
Female
Race
White
Black
Other
Marital Status
Married

Reference
206.85

59.93

0.001

Reference
51.45
31.89

77.96
87.12

0.509
0.714

185.29
96.59
66.36

0.089
0.939
0.001

118.60
93.23
110.24
129.07
110.07

0.624
0.101
0.015
0.048
0.032

93.45
62.82

0.083
<0.001

Reference

Widowed
-315.62
Divorced
7.40
Separated/never married
-216.98
Degree
No degree
Reference
GED
58.06
High School Diploma
152.84
Bachelor’s degree
269.14
Masters or Doctorate
255.36
Other degree
236.08
Insurance coverage
Private
Public
Uninsured
Hypertension

Reference
-161.95
-321.73
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Table 26. Cont’d
________________________________________________________________________
Marginal effect
Standard error
Prob.
________________________________________________________________________
No hypertension
Reference
Has hypertension
234.90
97.18
0.016
Hyperlipidemia
No hyperlipidemia
Reference
Has hyperlipidemia
-112.44
73.91
0.128
Anxiety
No anxiety
Reference
Has anxiety
141.66
107.16
0.186
Asthma
No asthma
Reference
Has asthma
-32.71
115.01
0.776
Charlson Comorbidity Index
212.28
45.58
<0.001
________________________________________________________________________
Marginal effects for dichotomous variables are change in the expected value of the dependent variable for the discrete
change from 0 to 1 of the independent variable, that is, from no osteoarthritis to osteoarthritis and females to males
Marginal effects for continuous variables are change in the expected value of the dependent variable for a unit change
in the independent variable, given a specific starting value for the independent variable
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SUMMARY AND CONCLUSIONS
Background
Osteoarthritis is the most common form of arthritis where there is progressive
degeneration of cartilage in the joint (Felson and Nevitt 2004). Symptoms of
osteoarthritis include pain, swelling or stiffness, or a combination (Altman, Alarcon et al.
1990). Joints commonly affected by osteoarthritis include knee, hip, hand, spine and foot
(Newman et al. 2003). In the United States, it was estimated that twenty-seven million
adults or 12.1 percent of the adult population suffered from osteoarthritis in 2005
(Lawrence, Felson et al. 2008). Risk of osteoarthritis increases with age (Felson,
Naimark et al. 1987; Kallman, Wigley et al. 1990; Losina, Weinstein et al. 2013).
Incidence of osteoarthritis is significantly greater in women than men (Oliveria, Felson et
al. 1995; Srikanth, Fryer et al. 2005). Occupations that include bending and lifting have
been associated with greater risk of osteoarthritis (Felson, Hannan et al. 1991; Coggon,
Kellingray et al. 1998). Strenuous physical activity (Buckwalter and Lane 1997; Kujala,
Kettunen et al. 1995) and genetic factors (Spector and MacGregor 2004) are some other
risk factors identified with osteoarthritis.
There is wide variation in the estimates of direct health care utilization and costs
among studies examining incremental costs due to osteoarthritis. This study provides a
current description of the utilization and expenditures of health care resources associated
with osteoarthritis. Estimates of incremental utilization and incremental costs of direct
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healthcare associated with osteoarthritis as well as incremental absenteeism and
incremental absenteeism costs associated with osteoarthritis were developed.

Objectives
The goal of this study was to assess burden associated with osteoarthritis. The
specific objectives of the study were to:
1. determine incremental annual direct health care resource utilization associated
with osteoarthritis by categories including hospitalizations, hospital days,
emergency room encounters, and outpatient visits
2. determine incremental annual direct health care expenditures associated with
osteoarthritis by categories including total expenditures, inpatient hospital
expenditures, emergency room expenditures, outpatient expenditures, medication
expenditures and miscellaneous expenditures
3. determine incremental annual number of days absent from work associated with
osteoarthritis and
4. determine incremental annual absenteeism costs associated with osteoarthritis
Hypotheses
The study hypotheses were:
1. presence of osteoarthritis will increase annual direct utilization of health care
resources, including increase in hospitalizations, hospital days, emergency room
encounters, and outpatient room visits
2. presence of osteoarthritis will increase annual direct health care expenditures,
including increase in total expenditures, inpatient hospital expenditures,
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emergency room expenditures, outpatient expenditures, medication expenditures
and miscellaneous expenditures
3. presence of osteoarthritis will increase annual absenteeism from workplace and
4. presence of osteoarthritis will increase annual absenteeism costs from workplace
Methods
An observational database analysis was conducted using data from the Medical
Expenditure Panel Survey (MEPS). Individuals eighteen years old or older with
osteoarthritis were compared to individuals without osteoarthritis. A one-year study
interval was used for analyses. The study was approved by the Institutional Review
Board of Purdue University.

Sample
Individuals eighteen years or older and employed in 2011 were included in the
study. ICD-9-CM codes were used to identify employees with osteoarthritis: 715 for
osteoarthritis and other allied disorders. Individuals diagnosed with osteoarthritis were
compared to individuals without any diagnosis of osteoarthritis. Individuals missing any
information on number of days missed at work in 2011 were excluded. Individuals who
had missing information for their wages in MEPS were excluded.

Study Variables
Study variables included a predictor variable of osteoarthritis that was coded as
‘1’ for presence of the disease and ‘0’ for absence of the disease. Covariates in the
model included age, coded as a continuous variable, gender, coded as a binary variable
with ‘0’ for males and ‘1’ for females. Race was coded as a categorical variable
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including “1” for White, “2” for Black,“3” for others. Region was coded as a categorical
variable including “1” for Northeast, “2” for Midwest, “3” for South, and “4” for West.
Marital status categories included “1” for married, “2” for widowed, “3” for separated,
“4” for divorced and “5” for never married. Highest degree obtained by an individual
was coded as “1” for no degree, “2” for general education degree (GED), “3” for high
school diploma, “4” for bachelor’s degree, “5” for master’s degree or doctorate degree
and “6” for other degree. Health insurance status was coded as a categorical variable
with three categories, “1” as private insurance, and “2” as public insurance and “3” for no
insurance. Comorbid disease conditions including hypertension, hyperlipidemia, anxiety
and asthma were also included. Each comorbid disease was coded as ‘1’ for presence of
the disease and ‘0’ for absence of the disease.
Annual wages were divided by number of working days in 2011 to obtain daily
wages. Daily wage was coded as a continuous variable. Daily wage was multiplied with
annual days missed at the workplace to obtain annual absenteeism costs.
Hospitalizations were determined by identifying and counting the number of
unique confinements per patient. Number of hospital days spent by each patient were
identified by subtracting the patient’s admit date and discharge date at the hospital for
each visit. One visit at an outpatient facility defined as a summation of all visits to that
facility per day. Similarly, for an emergency room visit if a patient visited an emergency
room once on a particular day, the resultant visit count for emergency room was one.
Total annual emergency room expenditures and total annual outpatient
expenditures per patient were calculated by adding facility-specific expenditures for the
patient in the specified one-year period. Total annual prescription expenditures per
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patient, were calculated by adding standard prices for all medication claims during the
specified one year period. Total miscellaneous expenditures per patient were calculated
by adding costs that did not belong in any other resource category during the specified
one year period.

Statistical Analyses
Data were analyzed using SAS for Unix Version 9.2 and STATA for Unix version
12. Frequency distributions were developed to describe the sample and Chi-square tests
were used to assess statistical differences between persons with osteoarthritis and those
without osteoarthritis on demographic variables and clinical variables. Unadjusted means
and 95 percent confidence intervals for annual hospitalizations, annual hospital stays,
annual outpatient visits and annual emergency room visits were computed and Wilcoxon
Mann Whitney tests were used to detect differences between the osteoarthritis and
comparator group. Similarly, unadjusted means and 95 percent confidence intervals were
developed for annual inpatient expenditures, annual outpatient expenditures, annual
emergency room expenditures, annual medication expenditures, annual miscellaneous
expenditures and annual total expenditures. Wilcoxon Mann Whitney tests were used to
detect differences between the osteoarthritis and comparator group. Unadjusted means
and 95 percent confidence intervals were calculated for annual absenteeism and annual
absenteeism costs. Wilcoxon Mann Whitney tests were used to detect differences
between the osteoarthritis and comparator group.
Individual zero inflated negative binomial regression models were developed to
estimate independent association between osteoarthritis and hospitalizations, hospital
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days, outpatient visits and emergency room visits. A binary predictor variable for
osteoarthritis was included in each model and covariates in each model included age,
gender, race, region, marital status, insurance, education, presence of comorbid diseases
including hypertension, hyperlipidemia, anxiety and asthma and Charlson Comorbidity
Index scores. Similar regression models for health care expenditures were developed,
with the predictor variable and covariates described above, with individual models for
total expenditures, hospital expenditures, outpatient expenditures, emergency room
expenditures, medication expenditures and total expenditures. Zero-inflated negative
binomial models were also developed for assessing association of osteoarthritis with
annual absenteeism and association of osteoarthritis with annual absenteeism costs.
Predictor variable and covariates as described above were included in the models.

Results and Discussion
Demographic characteristics of sample
The total number of individuals who participated in MEPS Household Component
of the Medical Expenditure Panel Survey in 2011 were 35,313. After excluding
individuals who were younger than eighteen years of age and unemployed, 26,992
individuals remained. Out of 26,992 individuals, 1,354 individuals had a diagnosis of
osteoarthritis, representing 15,363,338 persons with osteoarthritis nationally.

Incremental Annual Resource Utilization associated with Osteoarthritis
Annual mean incremental hospitalizations associated with osteoarthritis in the
current study were 0.07 hospitalizations (p<0.001). Mean annual hospital days were not
incrementally greater for individuals with osteoarthritis (0.06 days, p=0.287). Mean
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annual outpatient visits were significantly higher for individuals with osteoarthritis as
compared to individuals without osteoarthritis (3.63 visits, p<0.001). Mean annual
emergency room visits were significantly higher for individuals with osteoarthritis as
compared to individuals without osteoarthritis (0.009 visits, p<0.001).
Findings from this study are consistent with findings from prior studies that
reported higher utilizations for individuals with osteoarthritis as compared to individuals
without osteoarthritis. Le et al. and Berger et al., in different studies, compared
individuals with osteoarthritis with individuals without osteoarthritis using Marketscan
databases and calculated incremental healthcare utilization associated with osteoarthritis
(Le, Montejano et al. 2012; Berger, Hartrick et al. 2011). Mean annual incremental
outpatient visits in this current study was 3.63 visits which was similar to the mean
annual incremental outpatient visits reported by Le et al. at 3.1 visits and Berger et al. at
3.9 visits. However, when compared to findings by Le et al. (Le, Monjetano et al. 2012),
and findings by Berger et al. (Berger, Hartrick et al. 2011), incremental mean annual
hospitalization was lower in the current study at 0.07 annual mean visits, as compared to
the estimate provided by Le et al. and Berger et al. at 0.3 visits. Mean incremental
annual hospital days in the current study was 0.06 days as compared to 1.3 days as
reported by Berger and colleagues.
Berger et al. and Le et al. used samples similar to this current study by examining
individuals eighteen years or older and employed. A possible reason for variation in
utilization estimates across studies may include differences in the process of data
collection. Berger et al. and Le et al. estimated utilizations from MarketScan® database
which contains information from enrollment files and medical and outpatient pharmacy
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claims from a variety of private insurers that provide health care coverage to their
employees (Berger, Hartrick et al. 2011; Le, Montejano et al. 2012). However, the
current study employed MEPS database where the medical conditions and health care
utilization reported by the individual in the survey were recorded by the interviewer as
verbatim text, which was then coded by professional coders to fully-specified 2011 ICD9-CM codes. Researchers have reported that the ability of survey respondents to report
medical conditions that can be coded accurately should not be assumed to be precise in
MEPS (Cox and Iachan, 1987; Johnson and Sanchez, 1993). A study conducted by
Zuvekas and Olin, compared participants in MEPS from 2001 to 2003 with Medicare
coverage and matched them to their Medicare enrollment and claims data using Medicare
health insurance claim numbers (HICNs) or social security numbers (SSNs). The authors
reported that individuals in the MEPS underreported utilization of health care services
including underreporting of emergency room visits and physician office visits by 19
percent (Zuvekas and Olin. 2009). Lower utilization estimates in this current study can
be attributed to the underreporting in the MEPS survey by individuals.

Incremental Annual Expenditures associated with Osteoarthritis
In the current study, mean annual incremental total expenditures associated with
osteoarthritis were $2,045.75 (p=0.001). Mean incremental inpatient expenditures were
the largest component of direct health expenditures at $826.83 (p=0.021). Mean
incremental outpatient expenditures were significantly associated with osteoarthritis at
$658.94 (p<0.05). Mean annual incremental medications expenditures associated with
osteoarthritis were $325.03 (p=0.013). Mean annual incremental emergency

128
expenditures was not significantly associated at $11.93 (p<0.687). Similarly, mean
annual incremental miscellaneous expenditures associated with osteoarthritis were $27.96
(p=0.117).
In previous studies, incremental expenditures associated with osteoarthritis were
reported with higher estimates. Le and colleagues evaluated 258,237 individuals with
osteoarthritis and matched them to the same number of individuals without osteoarthritis,
using Marketscan® databases. They estimated mean total costs associated with
osteoarthritis at $10,941 (Le, Montejano et al. 2012). Similarly, Berger and colleagues
using Marketscan® databases for 2007, estimated mean total costs associated with
osteoarthritis at $8,060 (Berger, Hartrick et al. 2011). The authors reported that presence
of comorbidities including diabetes, hypertension, and cardiovascular disease which were
not adjusted in the analyses could have resulted in high expenditure estimates (Berger,
Hartrick et al. 2011; Le, Montejano et al. 2012).
By using survey weights for MEPS, national estimates for this population of
employed, individuals eighteen years or older were obtained for the current study. A
sample of 26,992 individuals in this study represents a population of 204,328,545
nationally. Total direct expenditures for this population was estimated at $41.7 billion
with annual inpatient expenditures as major contributor at $16.8 billion dollars, followed
by outpatient expenditures at $13.4 billion dollars, annual medication expenditures at
$6.6 billion dollars, annual miscellaneous expenditures at 0.57 billion and annual
emergency room expenditures at $0.24 billion.
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Incremental Annual Absenteeism associated with Osteoarthritis
Mean incremental absenteeism associated with osteoarthritis in the current study
was estimated at 2.2 days annually. Findings from previous studies in estimating annual
incremental absenteeism were similar. Berger et al. estimated annual incremental
absenteeism costs between individuals with osteoarthritis and individuals without
osteoarthritis using MarketScan® databases in 2007. Annual incremental absenteeism
related to sickness was estimated at 1.8 days (Berger, Hartrick et al. 2011). Kotlarz and
colleagues evaluated pooled data from 1996 to 2005 from MEPS and estimated
incremental mean annual absenteeism of 1.8 days for women and 1.65 days for men due
to osteoarthritis (Kotlarz, Gunnarsson et al. 2010). Kotlarz et al. did not provide an
annual average absenteeism estimate for an individual, irrespective of the gender.

Incremental Annual Absenteeism Expenditures associated with Osteoarthritis
Current study estimated mean annual incremental absenteeism costs at $715.74.
Absenteeism costs were estimated by employing annual wages reported by individuals in
MEPS in 2011. However, 50 percent of the sample reported zero wages, despite being
employed. By removing the individuals who reported zero wages, the mean incremental
absenteeism costs increased slightly by $784.37. After removing individuals who
reported zero wages, the number of individuals who remained in the sample were 10,320.
After applying survey weights, 10,320 individuals were equivalent to a population of
112,603,572 to obtain a population of employed, eighteen years or older individuals with
wages greater than zero. The mean absenteeism costs for this population was $8.8 billion
dollars. Kotlarz and colleagues using MEPS data estimated an aggregate annual

130
absenteeism costs of $4.8 billion for women and $5.5 billion for men. Kotlarz and
colleagues obtained the above costs by utilizing information from Morbidity and
Mortality Weekly Report from Centers of Disease Control and Prevention, instead of
completely relying on MEPS (Kotlarz, Gunnarsson et al. 2010). This could explain the
discrepancy in the absenteeism costs reported between the current study and by Kotlarz et
al.

Study Limitations
A limitation of this study was that ICD-9-CM codes were used to identify
individuals with osteoarthritis. Also, the comorbidities used for the Charlson
Comorbidity Index were identified using ICD-9-CM codes. Use of diagnostic codes in
claims to identify diagnosis is known to be imperfect due to variations in coding
(Romano and Mark 1994). However, the set of codes used in this study to identify
osteoarthritis have been utilized in prior studies (Berger, Hartrick et al 2011; Le et al.
2012). Another limitation of this study was that MEPS does not specify the site of
osteoarthritis (knee or hip or hand) and thus it is not possible to evaluate associations
between site of osteoarthritis and expenditures associated with it. Absenteeism is selfreported in MEPS and this could cause variations while estimating absenteeism costs.

Conclusions
The study findings indicate that osteoarthritis is associated with significant
incremental health care resource utilization and incremental health care expenditures
even after adjusting for age, gender, race, region, marital status, insurance, Charlson
comorbidity score, hypertension, hyperlipidemia, anxiety and asthma. Significant
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incremental mean annual resource utilization associated with osteoarthritis for
hospitalizations (0.07), outpatient visits (3.63 visits), and emergency room visits (0.09
visits) were observed. Considerable mean total annual incremental expenditures of
$2,045.75 associated with osteoarthritis were observed. The highest contributor to total
direct expenditures were from hospital expenditures ($826.38), followed by outpatient
expenditures ($658.94) and medication expenditures ($325.03). Significant mean
incremental annual absenteeism at 2.21 days and mean incremental annual absenteeism
costs at $715.75 were attained in this current study. These findings indicate that
presence of osteoarthritis has a significant economic burden, through direct healthcare
expenditures and indirect expenditures.

132

Notes
Berger, Ariel, Craig Hartrick, John Edelsberg, Alesia Sadosky and Gerry Oster.2011.
Direct and indirect economic costs among private-sector employees with
osteoarthritis. Journal of Occupational and Environmental Medicine 53(11):12281235.
Buckwalter JA, C Saltzman and T Brown. 2004. The impact of osteoarthritis:
implications for research. Clinical Orthopedics and Related Research (427
Suppl):S6-15.
Cox, Brenda and Ronaldo Iachan. 1987. A Comparison of Household and Provider
Reports of Medical Conditions. Journal of the American Statistical Association
82(400):1013-18.
Johnson, A.E. and Sanchez, M.E. 1993. Household and Medical Provider Reports on
Medical Conditions: National Medical Expenditure Survey, 1987. Journal of
Economic and Social Measurement. Vol. 19, 199-233.
Kotlarz, Harry, Candace L. Gunnarsson, Hai Fang and John A. Rizzo. 2009. Insurer and
Out-of-Pocket Costs of Osteoarthritis in the US.Evidence From National Survey
Data. Arthritis & Rheumatology 60: 3546-3553.
Kotlarz, Harry, Candace L. Gunnarsson, Hai Fang and John A. Rizzo. 2010.
Osteoarthritis and absenteeism costs: evidence from US National Survey Data.
Journal of Occupational and Environmental Medicine 52(3): 263-268.
Le, Kim, Leslie Montejano LB, Zhun Cao, Yang Zhao and Dennis Ang. 2012. Health
care costs in US patients with and without a diagnosis of osteoarthritis. Journal of
Pain Research. 5:23-30.
M. Lethbridge-Cejku, C. G. Helmick, and J. R. Popovic. 2003. Hospitalizations for
arthritis and other rheumatic conditions data from the 1997 National Hospital
Discharge survey. Medical Care 41(12):1367–1373.
Romano, Patrick S., and David H. Mark. 1994. Bias in the Coding of Hospital Discharge
Dataand Its Implications for Quality Assessment. Medical Care 32 (1): 81-90.
Zuvekas, Samuel and Gary Olin. 2009. Accuracy of Medicare expenditures in the
medical expenditure panel survey. Inquiry. 46(1):92-108.
Zuvekas, Samuel and Gary Olin. 2009. Validating household reports of health care use in
the medical expenditure panel survey. Health Services Research.44:1679-700.

141

BIBLIOGRAPHY

133

BIBLIOGRAPHY

Altman, R., G. Alarcon, D Appelrouth, D Bloch, D Borenstein, K Brandt, C Brown, TD
Cooke, W Daniel, R Gray, et al. et al. 1990. The American College of
Rheumatology criteria for the classification and reporting of osteoarthritis of the
hand. Arthritis and Rheumatology 33(11): 1601-1610.
Altman, R., E. Asch, D.Bloch, G.Bole, D. Borenstein, K.Brandt, W,Christy, TD Cooke
R Greenwald, M Hochberg, et al. 1986. Classification of osteoarthritis of the
knee. Diagnostic and Therapeutic Criteria Committee of the American
Rheumatism Association. Arthritis and Rheumatology 29(8): 1039-1049.
Anderson, Jennifer. J. and David T. Felson. 1988. Factors associated with osteoarthritis
of the knee in the first national Health and Nutrition Examination Survey
(HANES I). Evidence for an association with overweight, race, and physical
demands of work. American Journal of Epidemiology 128(1): 179-189.
Badley, Elizabeth M. and Peizhong Peter Wang. 1998. Arthritis and the aging population:
projections of arthritis prevalence in Canada 1991 to 2031. Journal of
Rheumatology 25(1): 138-144.
Baum, Carlene, Dianne L. Kennedy and Mary B.Forbes. 1985. Utilization of nonsteroidal
antiinflammatory drugs. Arthritis and Rheumatology 28(6): 686-692.
Beaton, Dorcas E., Claire Bombardier, Reuben Escorpizo, Wei Zhang, Diane Lacaille,
Annelies Boonen, Richard H Osborne, Aslam H Anis, Strand CV, Tugwell PS.
2009. Measuring worker productivity: frameworks and measures. Journal of
Rheumatology 36(9): 2100-2109.
Beaton, Dorcas E., Kenneth Tang, Monique M.Gignac, Diane Lacaille, Elizabeth
M.Badley, Aslam H.Anis and Claire Bombardier. 2010. Reliability, validity, and
responsiveness of five at-work productivity measures in patients with rheumatoid
arthritis or osteoarthritis. Arthritis Care Research (Hoboken) 62(1): 28-37.
Belo, Janneke N., Marjolein. Y. Berger, Bart W. Koes, and Sita M.Bierma-Zeinstra.
2009. Prognostic factors in adults with knee pain in general practice. Arthritis
andRheumatology 61(2): 143-151.

134
Berger, Ariel, Craig Hartrick, John Edelsberg, Alesia Sadosky and Gerry Oster.2011.
Direct and indirect economic costs among private-sector employees with
osteoarthritis. Journal of Occupational and Environmental Medicine 53(11):12281235
Berger, Marc, James F. Murray, Judy Xu and Mark Pauly. 2001. Alternative valuations
of work loss and productivity. Journal of Occupational and Environmental
Medicine 43(1): 18-24.
Blixen, Carol E. and Christopher Kippes 1999. Depression, social support, and quality of
life in older adults with osteoarthritis. Journal of Nursing Scholarship 31(3): 221226.
Brouwer, Werner B., Mark A. Koopmanschap and Frans F.H. Rutten. 1997. Productivity
costs in cost-effectiveness analysis: numerator or denominator: a further
discussion. Health Economics 6(5): 511-514.
Brouwer, Werner B., Mark A. Koopmanschap, and Frans F.H. Rutten. 1999. Productivity
losses without absence: measurement validation and empirical evidence. Health
Policy 48(1): 13-27.
Brouwer, Werner B., N. J. van Exel, Mark A. Koopmanschap, and Frans F.H. Rutten.
2002. Productivity costs before and after absence from work: as important as
common? Health Policy 61(2): 173-187.
Bruyere, O., K. Pavelka, et al. 2008. Total joint replacement after glucosamine sulphate
treatment in knee osteoarthritis: results of a mean 8-year observation of patients
from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis
Cartilage 16(2): 254-260.
Buckwalter, Joseph A. and Nancy E. Lane. 1997. Athletics and osteoarthritis. American
Journal of Sports Medicine 25(6): 873-881.
Burton, Wayne, Alan Morrison, Ross Maclean and Eric Ruderman. 2006. Systematic
review of studies of productivity loss due to rheumatoid arthritis. Occupational
Medicine (Lond) 56(1): 18-27.
Busija, Lucy, Rachelle Buchbinder and Richard H.Osborne. 2013. A grounded patientcentered approach generated the personal and societal burden of osteoarthritis
model. Journal of Clinical Epidemiology 66(9): 994-1005.
Caudill-Slosberg, Margaret A., Lisa M. Schwartz and Steven Woloshin. 2004. Office
visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000.
Pain 109(3): 514-519.
Chen, A., C. Gupte, et al. 2012. The Global Economic Cost of Osteoarthritis:How the UK
Compares. Arthritis 2012: 6

135
Clegg, Daniel. O., Domenic J. Reda, Crystal L. Harris, Marguerite A. Klein, James R.
O’Dell, Michele M. Hooper, John D. Bradley, Clifton O. Bingham III,Michael H.
Weisman, Christopher G. Jackson, et al. 2006. Glucosamine, chondroitin sulfate,
and the two in combination for painful knee osteoarthritis. New England Journal
of Medicine 354(8): 795-808.
Coggon, David, Samantha Kellingray, Hazel Inskip, Peter Croft, Lesley Campbell and
Cyrus Coope. 1998. Osteoarthritis of the hip and occupational lifting. American
Journal of Epidemiology 147(6): 523-528.
Cohen, Joel W., Alan C. Monheit, Karen Beauregard et al. 1996. The Medical
Expenditure Panel Survey: a national health information resource. Inquiry 33(4):
373-389.
Coleman, Cynthia M., Caroline Curtin, Frank P. Barry, Cathal O'Flatharta, and J. Mary
Murphy. 2010. Mesenchymal stem cells and osteoarthritis: remedy or
accomplice? Human Gene Therapy 21(10): 1239-1250.
Collins, James J., Catherine Baase, Claire Sharda, Ronald Ozminkowski, Sean
Nicholson, Gary M. Billotti, Robin S.Turpin, Michael Olson and Marc Berger.
2005. The assessment of chronic health conditions on work performance, absence,
and total economic impact for employers. Journal of Occupational and
Environmental and Medicine 47(6): 547-557.
Combe, Bernard, Gary Swergold, James McLay, Timothy McCarthy, Cristiano Zerbini,
Paul Emery, Laurine Connors, Amarjot Kaur, Sean Curtis, Loren Laine and
Christopher P. Cannon. 2009. Cardiovascular safety and gastrointestinal
tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial
(The MEDAL study). Rheumatology (Oxford) 48(4): 425-432.
Cowan, Sallie M., Kim L. Bennell, Paul W.Hodges, Kay M Crossley and Jenny
McConnell. 2001. Delayed onset of electromyographic activity of vastus medialis
obliquus relative to vastus lateralis in subjects with patellofemoral pain syndrome.
Archives of Physical Medicine and Rehabilitation 82(2): 183-189.
Cox, Brenda and Ronaldo Iachan. 1987. A Comparison of Household and Provider
Reports of Medical Conditions. Journal of the American Statistical Association
82(400):1013-18.
Dibonaventura, Marco, Shaloo Gupta, Margaret McDonald and Alesia Sadosky. 2011.
Evaluating the health and economic impact of osteoarthritis pain in the workforce:
results from the National Health and Wellness Survey. BMC Musculoskeletal
Disorders 12: 83.

136
Dunbar, Stuart A. and Nathaniel P. Katz. 1996. Chronic opioid therapy for nonmalignant
pain in patients with a history of substance abuse: report of 20 cases. Journal of
Pain and Symptom Management 11(3): 163-171.
Dunlop, Dorothy D., Larry M. Manheim, Edward H. Yelin, Jing Song and Rowland W.
Chang. 2003. The costs of arthritis. Arthritis and Rheumatology 49(1): 101-113.
Escorpizo, Reuben., Claire Bombardier, et al. 2007. Worker productivity outcome
measures in arthritis. Journal of Rheumatology 34(6): 1372-1380.
Felson, David T, Marian T Hannan, Allan Naimark, Jennifer Berkeley, Gordon G,
Wilson PW, Anderson J. 1991. Occupational physical demands, knee bending,
and knee osteoarthritis: results from the Framingham Study. Journal of
Rheumatology 18(10): 1587-1592.
Felson, David T., Reva C. Lawrence, Paul A. Dieppe, Rosemarie Hirsch, Charles G.
Helmick, Joanne M. Jordan, Raynard S. Kington, Nancy E. Lane, Michael C.
Nevitt, Yuqing Zhang, MaryFran Sowers, Timothy McAlindon, Tim D. Spector et
al. 2000. Osteoarthritis: new insights. Part 1: the disease and its risk factors.
Annals of Internal Medicine 133(8): 635-646.
Felson, David T., Allan Naimark, Jennifer Anderson, Lewis Kazis, William Castelli and
Robert F. Meenan. 1987. The prevalence of knee osteoarthritis in the elderly. The
Framingham Osteoarthritis Study. Arthritis and Rheumatology 30(8): 914-918.
Felson, David T. and Yuqing Zhang. 1998. An update on the epidemiology of knee and
hip osteoarthritis with a view to prevention. Arthritis and Rheumatology 41(8):
1343-1355.
David T. Felson, Yuqing Zhang, John M. Anthony, Allan Naimark, and Jennifer J.
Anderson. 1992. Weight loss reduces the risk for symptomatic knee osteoarthritis
in women. The Framingham Study. Annals of Internal Medicine 116(7): 535-539.
Ivana Filipovic, David Walker, Fiona Forster and Alistair S. Curry. 2011. Quantifying the
economic burden of productivity loss in rheumatoid arthritis. Rheumatology
(Oxford) 50(6): 1083-1090.
Fortin, Paul R, John R. Penrod, Ann E. Clarke, Yvan St-Pierre, Lawrence Joseph,
Patrick Bélisle, Matthew H. Liang, Diane Ferland, Charlotte B. Phillips, Nizar
Mahomed, Michael Tanzer, Clement Sledge, Anne H. Fossel and Jeffrey N. Katz.
2002. Timing of total joint replacement affects clinical outcomes among patients
with osteoarthritis of the hip or knee. Arthritis and Rheumatology 46(12): 33273330.
Gabriel, S. E., C. S. Crowson, et al. 1997. Direct medical costs unique to people with
arthritis. Journal of Rheumatology 24(4): 719-725.

137
Gabriel, S. E., C. S. Crowson, et al. 1997. Indirect and nonmedical costs among people
with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
Journal of Rheumatology 24(1): 43-48.
Gignac, Monique A., Catherine L. Backman, Aileen M. Davis, Diane Lacaille, Xingshan
Cao and Elizabeth M. Badley. 2013. Social role participation and the life course
in healthy adults and individuals with osteoarthritis: are we overlooking the
impact on the middle-aged? Social and Science Medicine 81: 87-93.
Gignac, Monique A, Catherine Backman, Aileen Davis, Diane Lacaille, Mattison CA,
Montie P, Elizabeth Badley.2008. Understanding social role participation: what
matters to people with arthritis? Journal of Rheumatology 35(8): 1655-1663.
Graham, David Y. 2000. NSAID ulcers: prevalence and prevention. Modern
Rheumatology 10(1): 2-7.
Guccione, Andrew A., David T. Felson, Jennifer J. Anderson, John M. Anthony, Yuqing
Zhang, Peter W F. Wilson, Margaret Kelly-Hayes, Philip A. Wolf, Bernard E.
Kreger and William B. Kannel. 1994. The effects of specific medical conditions
on the functional limitations of elders in the Framingham Study. American
Journal of Public Health 84(3): 351-358.
Gupta, S., G. A. Hawker, et al. 2005. The economic burden of disabling hip and knee
osteoarthritis (OA) from the perspective of individuals living with this condition.
Rheumatology (Oxford) 44(12): 1531-1537.
Hadler, Nortin M., Nortin M. Hadler, Dennis B. Gillings, Harold R. Imbus, Peter M.
Levitin, Diane Makuc, Peter D. Utsinger, William J. Yount, Derwood Slusser,
andNancy Moskovitz. 1978. Hand structure and function in an industrial setting.
Arthritis and Rheumatology 21(2): 210-220.
Hadley, Nancy A., Thomas D. Brown and Stuart L. Weinstein. 1990. The effects of
contact pressure elevations and aseptic necrosis on the long-term outcome of
congenital hip dislocation. Journal of Orthopedic Research 8(4): 504-513.
Hagen, Knut, John-Anker Zwart, Sven Svebak, Gunnar Bovim, Lars Jacob Stovner.
2005. Low socioeconomic status is associated with chronic musculoskeletal
complaints among 46,901 adults in Norway. Scandinavian Journal of Public
Health 33(4): 268-275.
Hawker, G., L. Stewart, M. R. French, J. Cibere, J. M. Jordan,L. March, M. SuarezAlmazor and R. Gooberman-Hill. 2008. Understanding the pain experience in hip
and knee osteoarthritis--an OARSI/OMERACT initiative. Osteoarthritis Cartilage
16(4): 415-422

138
Helmick, Charles, David T. Felson, Reva C. Lawrence, Sherine Gabriel,Rosemarie
Hirsch, C. Kent Kwoh, Matthew H. Liang, Hilal Maradit Kremers,Maureen D.
Mayes, Peter A. Merkel, Stanley R. Pillemer, John D. Reveille, and John H. Stone
2008. Estimates of the prevalence of arthritis and other rheumatic conditions in
the United States. Part I. Arthritis and Rheumatology 58(1): 15-25.
Hochberg, Marc C., D. L. Perlmutter, Donna L. Hudson, James I. and Altman, Roy D.
1996. Preferences in the management of osteoarthritis of the hip and knee: results
of a survey of community-based rheumatologists in the United States. Arthritis
Care and Research 9(3): 170-176.
Honkonen, S. E. 1995. Degenerative arthritis after tibial plateau fractures. Journal of
Orthopedic Trauma 9(4): 273-277.
Hootman, Jennifer M. and Charles G. Helmick. 2006. Projections of US prevalence of
arthritis and associated activity limitations. Arthritis and Rheumatology 54(1):
226-229.
Hutubessy, Raymond C., Maurits W. van Tulder, Hindrik Vondeling and Lex M. Bouter.
1999. Indirect costs of back pain in the Netherlands: a comparison of the human
capital method with the friction cost method. Pain 80(1-2): 201-207.
Jakobsson, U. and I. R. Hallberg. 2006. Quality of life among older adults with
osteoarthritis: an explorative study. Journal of Gerontological Nursing 32(8): 5160.
Johannesson, Magnus. 1996. The willingness to pay for health changes, the humancapital approach and the external costs. Health Policy 36(3): 231-244.
Johnson, A.E. and Sanchez, M.E. 1993. Household and Medical Provider Reports on
Medical Conditions: National Medical Expenditure Survey, 1987. Journal of
Economic and Social Measurement. Vol. 19, 199-233.
Jonsson, Helgi, Ileana Manolescu, Stefan Einar Stefansson, Thorvaldur Ingvarsson,
Hjortur H. Jonsson, Andrei Manolescu, Jeff Gulcher and Kari Stefansson. 2003.
The inheritance of hand osteoarthritis in Iceland. Arthritis and Rheumatology.
48(2): 391-395.
Jordan, J. M., C. G. Helmick, et al. 2007. Prevalence of knee symptoms and radiographic
and symptomatic knee osteoarthritis in African Americans and Caucasians: the
Johnston County Osteoarthritis Project. Journal of Rheumatology. 34(1): 172-180.
Kallman, D. A., F. M. Wigley, et al. 1990. The longitudinal course of hand osteoarthritis
in a male population. Arthritis and Rheumatology. 33(9): 1323-1332.

139
Kotlarz, Harry, Candace L. Gunnarsson, Hai Fang and John A. Rizzo. 2009. Insurer and
Out-of-Pocket Costs of Osteoarthritis in the US.Evidence From National Survey
Data. Arthritis & Rheumatology 60:3546-3553.
Kotlarz, Harry, Candace L. Gunnarsson, Hai Fang and John A. Rizzo. 2010.
Osteoarthritis and absenteeism costs: evidence from US National Survey Data.
Journal of Occupational and Environmental Medicine 52(3): 263-268.
Kujala, Urho M., Jyrki Kettunen, Heli Paananen, Teuvo Aalto, Michele C. Battié, Olli
Impivaara, Tapio Videman and Seppo Sarna. 1995. Knee osteoarthritis in former
runners, soccer players, weight lifters, and shooters. Arthritis and Rheumatology
38(4): 539-546.
Kurtz, Steven, Kevin Ong, Edmund Lau, Fionna Mowat and Michael Halpern. 2007.
Projections of primary and revision hip and knee arthroplasty in the United States
from 2005 to 2030. Journal of Bone and Joint Surgery Am 89(4): 780-785.
Lane, Nancy E., Thomas J. Schnitzer, Charles A. Birbara, Masoud Mokhtarani, David L.
Shelton, Mike D. Smith and Mark T. Brown. 2010. Tanezumab for the treatment
of pain from osteoarthritis of the knee. New England Journal of Medicine
363(16): 1521-1531.
Lanes, Stephen F., Lee L. Lanza, Paul W.Radensky, Robert A.Yood, Robert F.Meenan,
Alexander M.Walker and Nancy A. Dreyer. 1997. Resource utilization and cost of
care for rheumatoid arthritis and osteoarthritis in a managed care setting: the
importance of drug and surgery costs. Arthritis and Rheumatology 40(8): 14751481.
Lawrence, Reva C., David T. Felson, Charles G. Helmick, Lesley M. Arnold, Hyon Choi,
Richard A. Deyo, Sherine Gabriel, Rosemarie Hirsch, Marc C. Hochberg, Gene
G. Hunder, Joanne M. Jordan, Jeffrey N. Katz, Hilal Maradit Kremers, Frederick
Wolfe and National Arthritis Data Workgroup 2008. Estimates of the prevalence
of arthritis and other rheumatic conditions in the United States. Part II. Arthritis
and Rheumatology 58(1): 26-35.
Leardini, G., F. Salaffi, R.Caporali, B.Canesi, L.Rovati, R.Montanelli and Italian Group
for Study of the Costs of Arthritis. 2004. Direct and indirect costs of osteoarthritis
of the knee. Clinical and Experimental Rheumatology 22(6): 699-706.
Le Kim, Leslie Montejano LB, Zhun Cao, Yang Zhao and Dennis Ang. Health care costs
in US patients with and without a diagnosis of osteoarthritis. Journal of Pain
Research. 5:23-30.

140
Le Li, X., M. A. Gignac and A.H. Anis. 2006. The indirect costs of arthritis resulting
from unemployment, reduced performance, and occupational changes while at
work. Medical Care 44(4): 304-310.
MacLean, C. H., K. Knight, H.Paulus, R.H. Brook and PG Shekelle. 1998. Costs
attributable to osteoarthritis. Journal of Rheumatology 25(11): 2213-2218.
Maetzel, A., L. C. Li, J Pencharz, G Tomlinson, C Bombardier, the Community
Hypertension and Arthritis Project Study Team. 2004. The economic burden
associated with osteoarthritis, rheumatoid arthritis, and hypertension: a
comparative study. Annals of the Rheumatic Diseases 63(4): 395-401.
March, Lynette M. and Hanish Bagga. 2004. Epidemiology of osteoarthritis in Australia.
Medical Journal of Australia 180(5 Suppl): S6-10.
Meerding, W. J., W. Jzelenberg, M.A.Koopmanschap, J.L.Severens, and A.Burdorf
2005. Health problems lead to considerable productivity loss at work among
workers with high physical load jobs. Journal of Clinical Epidemiology 58(5):
517-523.
Milder, Tamara Y., Kenneth M. Williams, Jan E. Ritchie, Wendy L. Lipworth and
Richard O. Day. 2011. Use of NSAIDs for osteoarthritis amongst older-aged
primary care patients: engagement with information and perceptions of risk. Age
and Ageing 40(2): 254-259.
Murray, Christopher J. and Alan D. Lopez. 1997. Global mortality, disability, and the
contribution of risk factors: Global Burden of Disease Study. Lancet 349(9063):
1436-1442.
Neogi, Tuhina, David Felson, , Jingbo Niu, Michael Nevitt, Cora E Lewis, Piran
Aliabadi, Burt Sack, James Torner, Lawrence Bradley and Yuqing Zhang. 2009.
Association between radiographic features of knee osteoarthritis and pain: results
from two cohort studies. British Medical Journal 339: b2844.
Neogi, T., M. C. Nevitt, M. Yang, J.R. Curtis, J. Torner and D.T. Felso 2010.
Consistency of knee pain: correlates and association with function. Osteoarthritis
Cartilage 18(10): 1250-1255.
Nuesch, Eveline, Anne WS Rutjes, Elaine Husni, Vivian Welch and Peter Jüni. 2009.
Oral or transdermal opioids for osteoarthritis of the knee or hip. Cochrane
Database Systematic Reviews (4): CD003115.
Oliveria, Susan A., David T. Felson, John I.Reed, Priscilla A.Cirillo, and Alexander M.
Walker. 1995. Incidence of symptomatic hand, hip, and knee osteoarthritis among
patients in a health maintenance organization. Arthritis and Rheumatology 38(8):
1134-1141.

141
Rabenda, Veronique, Christelle Manette, Regine Lemmins, Anne-Marie Mariani, Nicole
Struvay and Jean-Yves Reginster. 2006. Direct and indirect costs attributable to
osteoarthritis in active subjects. Journal of Rheumatology 33(6): 1152-1158.
Rejeski, W. Jack, Walter H. Ettinger, Jr., Kathleen Martin, and Timothy Morgan. 1998.
Treating disability in knee osteoarthritis with exercise therapy: a central role for
self-efficacy and pain. Arthritis Care and Research 11(2): 94-101.
Rejeski, W. Jack, Brian C. Focht, Steven Messier, Tim Morgan, Marco Pahor and Brenda
Penninx. 2002. Obese, older adults with knee osteoarthritis: weight loss, exercise,
and quality of life. Health Psychology 21(5): 419-426.
Riddle, Daniel L., Xiangrong Kong and G. Kelley Fitzgerald. 2011. Psychological health
impact on 2-year changes in pain and function in persons with knee pain: data
from the Osteoarthritis Initiative. Osteoarthritis Cartilage 19(9): 1095-1101.
Ronn, Karolin, Nikolaus Reischl, Emanuel Gautier, and Matthias Jacobi. 2011. Current
surgical treatment of knee osteoarthritis. Arthritis 2011: 454873.
Runhaar, J., B. W. Koes, et al. 2011. A systematic review on changed biomechanics of
lower extremities in obese individuals: a possible role in development of
osteoarthritis. Obesity Reviews 12(12): 1071-1082.
Sacks, Jeffrey J., Yao H. Luo and Charles Helmick. 2010. Prevalence of specific types of
arthritis and other rheumatic conditions in the ambulatory health care system in
the United States, 2001-2005. Arthritis Care and Research (Hoboken) 62(4): 460464.
Salaffi, Fausto, Marina Carotti, Andrea Stancati, and Walter Grassi. 2005. Health-related
quality of life in older adults with symptomatic hip and knee osteoarthritis: a
comparison with matched healthy controls. Aging Clinical and Experimental
Research 17(4): 255-263.
Sale, Joanne E., Monique Gignac and Gillian Hawker. 2008. The relationship between
disease symptoms, life events, coping and treatment, and depression among older
adults with osteoarthritis. Journal of Rheumatology 35(2): 335-342.
Sellers, Rani S., Diane Peluso and Elizabeth Morris. 1997. The effect of recombinant
human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness
defects of articular cartilage. Journal of Bone and Joint Surgery Am 79(10):
1452-1463.
Sowers, Maryfran, Carrie A. Karvonen-Gutierrez, Riann Palmieri-Smith, Jon A.
Jacobson, Yebin Jiang and James A. Ashton-Miller. 2009. Knee osteoarthritis in
obese women with cardiometabolic clustering. Arthritis and Rheumatology
61(10): 1328-1336.

142
Sowers Maryfran, Lachance L, Hochberg M and Jamadar D. 2000. Radiographically
defined osteoarthritis of the hand and knee in young and middle-aged AfricanAmerican and Caucasian women. Osteoarthritis Cartilage. 8:69–77.
Spector, Tim D., Flavia Cicuttini, Juliet Baker, John Loughlin and Deborah Hart. 1996.
Genetic influences on osteoarthritis in women: a twin study. British Medical
Journal 312(7036): 940-943.
Spector, Tim D. and Alex J. MacGregor. 2004. Risk factors for osteoarthritis: genetics.
Osteoarthritis Cartilage 12 Suppl A: S39-44.
Sproule, Beth, Bruna Brands, Selina Li and Laura Catz-Biro. 2009. Changing patterns in
opioid addiction: characterizing users of oxycodone and other opioids. Canadian
Family Physician 55(1): 68-69, 69 e61-65.
Srikanth, Velandai K., Jayne L. Fryer, Guangju Zhai and Tania M. Winzenberg. 2005. A
meta-analysis of sex differences prevalence, incidence and severity of
osteoarthritis. Osteoarthritis Cartilage 13(9): 769-781.
Tang, Raymond S. and Francis K. Chan. 2012. Therapeutic management of recurrent
peptic ulcer disease. Drugs 72(12): 1605-1616.
Tannenbaum, H., P. M. Peloso, et al. 2000. An evidence-based approach to prescribing
NSAIDs in the treatment of osteoarthritis and rheumatoid arthritis: The Second
Canadian Consensus Conference. The Canadian Journal of Clinical Pharmacology
7 Suppl A: 4A-16A.
Tepper, S. and M. C. Hochberg. 1993. Factors associated with hip osteoarthritis: data
from the First National Health and Nutrition Examination Survey (NHANES-I).
American Journal of Epidemiology 137(10): 1081-1088.
Theis, Kristina A., Louise Murphy, Jennifer M. Hootman, Charles G. Helmick and
Edward Yelin. 2007. Prevalence and correlates of arthritis-attributable work
limitation in the US population among persons ages 18-64: 2002 National Health
Interview Survey Data. Arthritis and Rheumatology 57(3): 355-363.
Torio, Celeste M. and Roxanne M. Andrews. 2013. National Inpatient Hospital Costs:
The Most Expensive Conditions by Payer, 2011: Statistical Brief #160.
Woo, Jean, Edith Lau, Chak Sing Lau, Polly Lee, James Zhang, Timothy Kwok, Cynthia
Chan, P. Chiu, Kai Ming Chan, A. Chan and D. Lam. 2003. Socioeconomic
impact of osteoarthritis in Hong Kong: utilization of health and social services,
and direct and indirect costs. Arthritis and Rheumatology 49(4): 526-534.
Woolf, Anthony D. 2003. The bone and joint decade. strategies to reduce the burden of
disease: the Bone and Joint Monitor Project. Journal of Rheumatology Suppl 67:
6-9.

143
Woolf, Anthony D. and Bruce Pfleger. 2003. Burden of major musculoskeletal
conditions. Bulletin of World Health Organization 81(9): 646-656.
Zacny, James, George Bigelow, Peggy Compton, Kathleen Foley, Martin Iguchi and
Christine Sannerud. 2003. College on Problems of Drug Dependence taskforce on
prescription opioid non-medical use and abuse: position statement. Drug and
Alcohol Dependence 69(3): 215-232.
Zhang, Wei, Nick Bansback and Aslam H. Anis. 2011. Measuring and valuing
productivity loss due to poor health: A critical review. Social Science and
Medicine 72(2): 185-192.
Zhang, W., Nuki G, Moskowitz RW, Abramson S, Altman RD, Arden NK, BiermaZeinstra S, Brandt KD, Croft P, Doherty M, et al. 2010. OARSI recommendations
for the management of hip and knee osteoarthritis: part III: Changes in evidence
following systematic cumulative update of research published through January
2009. Osteoarthritis Cartilage 18(4): 476-499.
Zhang, Yuqing and Joanne M. Jordan. 2010. Epidemiology of osteoarthritis. Clinics in
Geriatric Medicine 26(3): 355-369.
Zhang, Yuqing, Jingbo Niu, Margaret Kelly-Hayes, Christine E. Chaisson, Piran
Aliabadi and David T. Felson. 2002. Prevalence of symptomatic hand
osteoarthritis and its impact on functional status among the elderly: The
Framingham Study. American Journal of Epidemiology 156(11): 1021-1027.
Zullig, Leah L., Hayden B. Bosworth, Amy S. Jeffreys, Leonor Corsino, Cynthia J.
Coffman, Eugene Z. Oddone, William S. Yancy Jr., and Kelli D. Allen. 2014. The
association of comorbid conditions with patient-reported outcomes in Veterans
with hip and knee osteoarthritis. Clinical Rheumatology.
Zuvekas, Samuel and Gary Olin. 2009. Accuracy of Medicare expenditures in the
medical expenditure panel survey. Inquiry. 46(1):92-108.
Zuvekas, Samuel and Gary Olin. 2009. Validating household reports of health care use in
the medical expenditure panel survey. Health Services Research.44:1679-700.

APPENDICES

144
Appendix A
Unadjusted Resource Utilization by Age, Gender and Comorbidities

145

Table A1. Unadjusted Annual Health Care Resource Utilization among Persons with Osteoarthritis by Age
____________________________________________________________________________________________________________
Under 35
35 to 44
45 to 54
55 to 64
65 and over
(n=45)
(n=73)
(n=195)
(n=389)
(n=651)
____________
___________
____________
__________
___________
Mean
Mean
Mean
Mean
Mean
Utilization Category
(95% CI)
(95% CI)
(95% CI)
(95% CI)
(95% CI)
____________________________________________________________________________________________________________
Hospitalizations
0.28
0.15
0.19
0.22
0.28
(0.13 to 0.43)
(0.05 to 0.25)
(0.11 to 0.27)
(0.16 to 0.27)
(0.22 to 0.33)
Hospital days

6.58
(2.35 to 7.03)

5.22
(2.16 to 8.26)

5.42
(1.63 to 9.21)

4.42
(2.98 to 5.45)

4.93
(3.85 to 6.01)

Outpatient visits

0.82
(0.07 to 1.57)

0.65
(0.22 to 1.08)

0.95
(0.48 to 1.42)

1.25
(0.75 to 1.25)

1.32
(1.03 to 1.60)

Emergency room visits

0.33
0.64
0.40
0.32
0.29
(0.12 to 0.53)
(0.35 to 0.93)
(0.26 to 0.53)
(0.24 to 0.39)
(0.23 to 0.35)
____________________________________________________________________________________________________________
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Table A2. Unadjusted Annual Health Care Resource Utilization among Persons with
Osteoarthritis by Gender
______________________________________________________________________
Female
Male
(N=952)
(N=402)
____________________
____________________
Mean
Mean
Utilization Category
(95% CI)
(95% CI)
______________________________________________________________________
Hospitalizations
0.23
0.26
(0.19 to 0.26)
(0.20 to 0.33)
Hospital days

5.19
(4.10 to 6.27)

5.98
(1.98 to 9.99)

Outpatient visits

1.25
(0.97 to 1.52)

1.06
(0.77 to 1.35)

Emergency room visits

0.36
0.27
(0.31 to 0.42)
(0.21 to 0.34)
______________________________________________________________________
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Table A3. Unadjusted Annual Health Care Resource Utilization among Persons with
Osteoarthritis and Presence or Absence of Hypertension
______________________________________________________________________
No Hypertension
Hypertension
(n=510)
(n=844)
____________________
____________________
Mean
Mean
Utilization Category
(95% CI)
(95% CI)
______________________________________________________________________
Hospitalizations
0.17
0.27
(0.13 to 0.22)
(0.23 to 0.32)
Hospital days

6.69
(1.86 to 11.51)

4.98
(3.98 to 5.98)

Outpatient visits

1.07
(0.67 to 1.46)

1.27
(1.02 to 1.51)

Emergency room visits

0.28
0.36
(0.22 to 0.35)
(0.31 to 0.42)
______________________________________________________________________
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Table A4. Unadjusted Annual Health Care Resource Utilization among Persons with
Osteoarthritis and Presence or Absence of Hyperlipidemia
______________________________________________________________________
No Hyperlipidemia
Hyperlipidemia
(n=663)
(n=691)
____________________
____________________
Mean
Mean
Utilization Category
(95% CI)
(95% CI)
______________________________________________________________________
Hospitalizations
0.19
0.28
(0.15 to 0.24)
(0.23 to 0.33)
Hospital days

5.70
(2.47 to 8.93)

5.28
(4.03 to 6.52)

Outpatient visits

1.14
(0.78 to 1.48)

1.25
(1.00 to 1.49)

Emergency room visits

0.33
0.34
(0.26 to 0.39)
(0.28 to 0.40)
______________________________________________________________________

149
Table A5. Unadjusted Annual Health Care Resource Utilization among Persons with
Osteoarthritis and Presence or Absence of Anxiety
______________________________________________________________________
No Anxiety
Anxiety
(n=1,150)
(n=204)
____________________
____________________
Mean
Mean
Utilization Category
(95% CI)
(95% CI)
______________________________________________________________________
Hospitalizations
0.22
0.31
(0.21 to 0.25)
(0.21 to 1.5)
Hospital days

5.59
(3.79 to 7.40)

4.81
(3.30 to 6.29)

Outpatient visits

1.22
(0.97 to 1.46)

1.05
(0.74 to 1.36)

Emergency room visits

0.29
0.56
(0.25 to 0.34)
(0.41 to 0.73)
______________________________________________________________________
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Table A6. Unadjusted Annual Health Care Resource Utilization among Persons with
Osteoarthritis and Presence or Absence of Asthma
______________________________________________________________________
No Asthma
Asthma
(n=1,150)
(n=204)
____________________
____________________
Mean
Mean
Utilization Category
(95% CI)
(95% CI)
______________________________________________________________________
Hospitalizations
0.23
0.27
(0.20 to 0.27)
(0.17 to 0.36)
Hospital days

5.49
(3.71 to 7.14)

5.59
(2.93 to 8.25)

Outpatient visits

1.03
(0.87 to 1.19)

2.18
(1.05 to 3.32)

Emergency room visits

0.33
0.37
(0.28 to 0.37)
(0.25 to 0.49)
______________________________________________________________________
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Table B1. Unadjusted Annual Health Care Expenditures in Dollars among Persons with Osteoarthritis by Age
____________________________________________________________________________________________________________
Under 35
35 to 44
45 to 54
55 to 64
65 and over
(n=46)
(n=73)
(n=195)
(n=389)
(n=651)
____________
____________
____________
____________
____________
Mean
Mean
Mean
Mean
Mean
Expenditure Category
(95% CI)
(95% CI)
(95% CI)
(95% CI)
(95% CI)
____________________________________________________________________________________________________________
Inpatient
3,365
1,742
4,805
4,396
2,912
expenditures
(684 to 6,046)
(312 to 3,172)
(3,806 to 10,322)
(2,752 to 6,040)
(2,259 to 3,564)
Outpatient
expenditures
Emergency room
expenditures
Medication
expenditures
Miscellaneous
Expenditures
Total health care
expenditures

3,090
(211 to 5,968)

3,052
(2,101 to 4,002)

2,726
(2,070 to 3,382)

3,778
(3,165 to 4,391)

3,108
(2,639 to 3,576)

323
(56 to 591)

557
(88 to 1,025)

298
(155 to 410)

329
(209 to 450)

242
(164 to 319)

838
(511 to 1,165)

1,430
(996 to 1,865)

3,304
(2,181 to 4,467)

2,147
(1,848 to 2,447)

2,428
(2,150 to 2,707)

79
(23 to 182)

67
(36 to 98)

157
(63 to 250)

157
(67 to 246)

229
(170 to 288)

7,695
(3,478 to 11,913)

6,849
(4,904 to 8,794)

11,290
(5,513 to 17,068)

10,809
(8,758 to 12,860)

8,921
(7,951 to 9,890)

_____________________________________________________________________________________________________________________
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Table B2. Unadjusted Annual Health Care Expenditures in Dollars among Persons with
Osteoarthritis by Gender
______________________________________________________________________
Male
Female
(n=402)
(n=952)
____________________
____________________
Mean
Mean
Expenditure Category
(95% CI)
(95% CI)
______________________________________________________________________
Inpatient expenditures
3,505
3,587
(2,515 to 4,494)
(2,259 to 4,916)
Outpatient expenditures
Emergency room expenditures
Medication expenditures
Miscellaneous expenditures
Total expenditures

3,056
(2,507 to 3,604)

3,320
(2,929 to 3,711)

254
(142 to 366)

312
(239 to 385)

2,200
(1,744 to 2,655)

2,436
(2,173 to 2,699)

180
(131 to 354)

189
(129 to 233)

9,195
9,844
(7,842 to 10,548)
(8,340 to 11,347)
______________________________________________________________________
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Table B3. Unadjusted Annual Health Care Expenditures in Dollars among Persons with
Osteoarthritis and Presence or Absence of Hypertension
______________________________________________________________________
No Hypertension
Hypertension
(n=510)
(n=844)
____________________
____________________
Mean
Mean
Expenditure Category
(95% CI)
(95% CI)
______________________________________________________________________
Inpatient expenditures
2,613
4,137
(1,725 to 3,501)
(2,661 to 5,612)
Outpatient expenditures

3,033
(2,538 to 3,528)

3,368
(2,951 to 3,784)

Emergency expenditures

263
(166 to 360)

314
(235 to 392)

Medication expenditures

2,100
(1,653 to 2,548)

2,526
(2,278 to 2,775)

191
(127 to 354)

180
(127 to 233)

Miscellaneous expenditures
Total expenditures

8,202
10,526
(6,982 to 9,243)
(8,871 to 12,182)
______________________________________________________________________
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Table B4. Unadjusted Annual Health Care Expenditures in Dollars among Persons with
Osteoarthritis and Presence or Absence of Hyperlipidemia
______________________________________________________________________
No Hyperlipidemia
Hyperlipidemia
(n=663)
(n=691)
____________________
____________________
Mean
Mean
Expenditure Category
(95% CI)
(95% CI)
______________________________________________________________________
Inpatient expenditures
2,690
4,496
(1,915 to 3,265)
(2,692 to 6,301)
Outpatient expenditures
Emergency room expenditures
Medication expenditures
Miscellaneous expenditures
Total expenditures

2,876
(2,477 to 3,274))

3,593
(3,098 to 4,047)

305
(208 to 402)

284
(209 to 359)

1,891
(1,541 to 2,241)

2,822
(2,527 to 3,116)

171
(105 to 236)

197
(147 to 246)

7,835
11,393
(6,856 to 8,814)
(9,393 to 13,393)
______________________________________________________________________
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Table B5. Unadjusted Annual Health Care Expenditures in Dollars among Persons with
Osteoarthritis and Presence or Absence of Anxiety
______________________________________________________________________
No Anxiety
Anxiety
(n=1,150)
(n=204)
____________________
____________________
Mean
Mean
Expenditure Category
(95% CI)
(95% CI)
______________________________________________________________________
Inpatient expenditures
3,488
3,985
(2,371 to 4,605)
(2,380 to 5,590)
Outpatient expenditures
Emergency room expenditures
Medication expenditures
Miscellaneous expenditures
Total health care expenditures

3,135
(2,779 to 3,490)

3,845
(3,154 to 4,536)

260
(201 to 320)

488
(260 to 717)

2,106
(1,884 to 2,328)

3,832
(2,988 to 4,675)

188
(141 to 235)

160
(209 to 212)

9,179
12,311
(7,914 to 10,444)
(9,990 to 14,633)
______________________________________________________________________
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Table B6. Unadjusted Annual Health Care Expenditures in Dollars among Persons with
Osteoarthritis and Presence or Absence of Asthma
______________________________________________________________________
No Asthma
Asthma
(n=1,162)
(n=192)
____________________
____________________
Mean
Mean
Expenditure Category
(95% CI)
(95% CI)
______________________________________________________________________
Inpatient expenditures
3,705
2,701
(2,578 to 4,832)
(1,643 to 3,759)
Outpatient expenditures
Emergency room expenditures
Medication expenditures
Miscellaneous expenditures
Total health care expenditures

3,084
(2,750 to 3,419)

4,193
(3,206 to 5,180)

219
(224 to 358)

317
(172 to 461)

2,105
(1,884 to 2,325)

3,947
(3,060 to 4,834)

195
(149 to 240)

120
(32 to 209)

9,382
11,279
(8,099 to 10,865)
(9,482 to 13,076)
______________________________________________________________________
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